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Abstract 
Clostridium difficile is the major cause of health-care associated infections. However 
the factors that participate in C. difficile infection and the processes that regulate 
their expression remains poorly understood. 
In Staphylococcus aureus, quorum sensing (QS) plays a central role in the regulation 
of virulence factors. The QS system of S. aureus is encoded by the accessory gene 
regulator (agr) locus and comprises of four genes. The pre-peptide (AgrD) is 
processed by AgrB and the mature auto-inducing peptide (AlP) is released into the 
medium. Free AlP binds to the histidine-sensor kinase AgrC, causing it to 
autophosphorylate. In turn, AgrC phosphorylates the response regulator AgrA, 
triggering an intracellular signal-transduction cascade which results in altered 
expression of several target genes. 
Homologues of genes involved in QS have been identified in the genome sequence 
of C. difficile 630, a virulent multidrug resistant strain. These homologues have also 
been identified in C. difficile R20291, a ribotype 027 epidemic strain, which has 
been characterised to produce increased quantities of Toxin A and Toxin B. C. 
difficile R20291 has two agr loci, whereas C. difficile 630 only has one agr locus. 
The first agr locus present in both strains contains agrBD homologues, although 
there are no apparent agrAlagrC homologues. However, the second agr locus in C. 
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difficile R20291 contains homologues of all four agr genes. Insertional inactivation 
of the QS homologues were made in the two C. difficile strains and the effects on 
virulence assessed. Cytotoxicity assays indicated that there is a substantial reduction 
in toxin B production in C. difficile R20291 strains deficient in the second agr 
system compared to the wild-type strain. Sporulation assays revealed that the onset 
of sporulation in the agr mutants vary greatly in comparison to the parental strain. 
The work presented in this study suggests that the agr system may be involved in 
toxin production and sporulation in C. difficile. 
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1.1 Introduction to clostridia 
Species that belong to the genus Clostridium are characterised as Gram-positive, 
anaerobic, catalase-negative, spore forming bacilli. Clostridium is one of the largest 
prokaryotic genera, containing over 300 species and is well known for its clinical 
importance and biotechnological potential (Andreesen et al., 1989). 
The species that make up Clostridium are highly diverse and the vast majority of 
them are entirely benign. Clostridia have a huge biotechnological and medical 
potential which will be industrially, medically and scientifically important in the 
future (Durre, 2001). The non-pathogenic Clostridium acetobutylicum is becoming 
of great interest because of its role in bio-butanol production (Jones and Woods, 
1986; Lee et al., 2008). As genome sequence data and DNA mutagenesis tools are 
now readily available, recombinant strains with superior biobutanol-producing 
ability can be engineered (Durre, 2007; 2008). Furthermore, the use of clostridial 
spores in cancer therapy has also been described for Clostridium sporogenes and 
Clostridium novyi (Minton et aI., 1995; Minton 2003; Theys et al., 2006 Mengesha 
et aI, 2010). 
Even though there are a number clostridial species which have shown to have many 
beneficial properties, on the other hand the pathogenic clostridia continue to 
overshadow this. Pathogenic clostridia cause disease by the release of potent toxins; 
enterotoxins by Clostridium perjringens, cytotoxins by Clostridium difficile, and 
neurotoxins by Clostridium botulinum and Clostridium tetani. In fact tetanus and 
botulinum neurotoxins, produced by Clostridium tetani and Clostridium botulinum 
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respectively, are two of the most harmful natural compounds known to man. Both 
produce neurotoxins that are lethal in very low concentrations (Durre, 2001). The 
estimated lethal dose of C. botulinum neurotoxin type A for a human of 70 kg is 
approximately 70 J.1g orally and 0.7-0.9 J.1g if inhaled (Amon et al., 2001). 
C. perfringens produces a number of extracellular toxins and enzymes associated 
with gas gangrene and clostridial myonecrosis in humans and animals (Collie et al., 
1998). C. botulinum is widely used in the cosmetics industry and is of importance for 
a number of medical applications. However, it has long been associated with food 
poisoning and bio-terrorism concerns due to its production of the most potent natural 
toxin known to man (Schantz and Johnson, 1992). The most recent publicised 
pathogenic clostridia IS Clostridium difficile; the causative agent of 
pseudomembranous colitis and antibiotic-associated diarrhoea. 
1.2 Clostridium dijJici/e 
Clostridium difficile was first discovered in 1935 (Hall and Toole, 1935), however it 
was only in 1978 that C. difficile was identified as an etiological agent of antibiotic-
associated diarrhoea (AAD) and pseudomembranous colitis (PMC) (Larson et al., 
1978). C. difficile is now recognised as the leading cause of antibiotic associated 
diarrhoea (AAD) in hospitals worldwide and has a huge impact on healthcare 
services (Sebaihia et al., 2006). 
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1.2.1 Epidemiology 
The impact of Clostridium difficile-associated disease (CDAD) in European 
hospitals and healthcare settings is considerable. During outbreaks of CDAD in a 
healthcare setting comprehensive infection control measures need to be taken, 
patients need to be isolated and require alternate therapy for underlying diseases as 
well as specific therapy for CDAD, wards are closed, and environmental 
decontamination is required (Wilcox et aI., 1996; Zafar et a.l, 1998; Oldfield, 2004; 
Song et al., 2008). 
In 1990, a voluntary surveillance scheme was introduced whereby the number of 
positive C. difficile laboratory samples in England and Wales were reported. Over 
the following 15 years after the introduction of the surveillance scheme, the 
incidence of CDAD rose dramatically (Figure 1.1). Subsequently in 2004, a 
mandatory surveillance scheme was introduced which required all National Health 
Service Trusts in England to report cases of CDAD in patients aged 65 and over. 
Following this, similar mandatory surveillance schemes have been implemented 
across the United Kingdom. These schemes cover all patients from the age of 2 years 
or over, enabling an accurate assessment of the incidence of CDAD to be achieved. 
In 2008, it was reported that C. difficile was the underlying cause of more than 2500 
deaths in England and Wales alone (Figure 1.2), ten times more deaths were caused 
by C. difficile than by methicillin-resistant Staphylococcus aureus (Office for 
National Statistics, UK: http://www.statistics.gov.uk). 
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Figure 1.1. Reports of posItive C. difficile laboratory samples isolated from faecal 
specimens under the voluntary reporting scheme in England between 1990 and 2005. From 
the website of the Health Protection Agency (http://www.hpa.org.uk). 
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Figure 1.2. Number of death certificates mentioning C. difficile in comparison to where C. 
difficile was noted as the underlying cause of death in England and Wales between 1999 and 
2008. Data was unavailable for 2000. A mandatory surveillance scheme was introduced 
between 2004 and 2005, which may partly account for the large increase in C. difficile 
incidence in the following years. From the website for the Office of National Statistics 
(http://www.statistics.gov.uk). 
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1.2.2 Clostridium difJicile-associated disease 
Clinical manifestations caused by C. difficite ranges from asymptomatic carriage to 
self-limiting antibiotic associated diarrhoea (AAD) to life-threatening colitis, toxic 
megacolon and death (Pox ton et at., 200 I; Sambol et at., 2000; Gerding, 1989). 
Elderly and immunocompromised patients are most susceptible to CDAD; 80% of 
cases occur in those over 65 years of age. Healthy individuals rarely develop CDAD, 
however hospitalised patients whose normal gut flora has been disturbed by the use 
of broad-spectrum antibiotics are highly susceptible (Johnson et at., 1999). The 
spores produced by C. difficite are extremely difficult to remove from institutional 
settings (i.e. hospitals and nursing homes), and a new source of infection is nearly 
always present. Past studies have shown that there is a 20-30% colonisation rate of 
hospitalised adults compared to 2-3% colonisation rate in healthy adults (Kyne et at., 
2002). These figures highlight the widespread contamination of hospital 
environments especially in areas associated with infection (Gerding et at., 1995; 
Fekety and Shah, 1993). 
1.2.3 Treatment 
There are a large number of mobile genetic elements in the C. difficile genome that 
carry antibiotic resistance genes making treatment of CDAD far from 
straightforward (Sebaihia, et at., 2006). As CDAD development is associated with 
antibiotic disruption of the gut flora, mild disease may be treated by withdrawing the 
previously administered antibiotics and providing further supportive therapy (Hedge, 
et at., 2008). The antibiotics recommended to treat CDAD are metronidazole in the 
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first instance, followed by vancomYCIn if the patient does not respond. The 
pharmacological properties of vancomycin make it the ideal drug to treat pathogens 
that act in the colonic lumen, yet metronidazole is the recommended agent due to its 
lower cost and the assumption that vancomycin promotes colonization of 
vancomycin-resistant enterococci (Gerding, 1997). The antibiotics, metronidazole 
and vancomycin, combined with patient isolation procedures, remain the principal 
therapeutic option for the treatment of CD AD. 
One of the complications facing antibiotic treatment of CDAD is relapse of infection 
once antibiotic treatment is terminated (Teasley et aI., 1983). Although some studies 
have suggested an increased failure rate of metronidazole in CDAD, it remains the 
recommended first line treatment for uncomplicated cases (Cloud and Kelly, 2007). 
These observations illustrate the contradiction in terms that oral vancomycin and 
metronidazole both cause and cure antibiotic-associated diarrhoea. This highlights 
the need of alternative approaches, more effective measures to treat CDAD 
(McFarland, 2005). 
1.2.4 Clostridium difficile virulence factors 
Whilst the toxins of C. difficile are clearly the principal virulence factors, the role of 
other virulence factors is much more speculative. The unique surface layer proteins 
of C. difficile vegetative cells are potential virulence factors and are thought to be 
involved in adherence of C. difficile to host cells, and eliciting inflammatory and 
antibody responses (Drudy, et al., 2004; Ausiello, et al., 2006; Rupnik, et aI., 2009). 
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In addition, it has been suggested that FliC and PliD, key components of the C. 
difficile flagella, are involved in adherence and gut colonisation (Tasteyre, et aI., 
2001). 
In addition to the toxins, another important virulence factor of C. difficile is its 
ability to produce endospores, which are thought to be key for transmission of 
CDAD. Bacterial spores are extremely resistant to all kinds of chemical and 
physical agents and provide the mechanism by which C. difficile can evade the 
potentially fatal consequences of exposure to heat, oxygen, alcohol and certain 
disinfectants (Setlow, 2007). The spores shed in faecal matter are very difficult to 
eradicate and can persist on contaminated surfaces in healthcare facilities for 
extended periods of time (Setlow, 2007). This leads to infection or re-infection of 
cohabiting individuals through inadvertent ingestion of contaminated material 
(Riggs, et aI., 2007; Gerding, et al., 2008). Once in the anaerobic environment of the 
gut, spores are able to germinate yielding the characteristic toxin-producing 
vegetative cells and, in susceptible individuals, diarrhoeal disease. 
1.2.5 Toxins 
The two major toxins produced by virulent strains of C. difficile, toxin A (TcdA) and 
toxin B (TcdB), are recognised as the main virulent factors (Borriello et aI., 1990). 
These toxins belong to the group of bacterial toxins called Large Clostridial 
cytoToxins (LCT's) (Just and Gerhard, 2004). Their structure is organised into three 
regions; the N-terminal region contains the catalytically active glucosyltransferase 
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site (Hoffman et al., 1997), the hydrophobic central region, which is involved in 
translocation of the toxins across the cell membrane (Pfeifer et al., 2003), and the C-
terminal region which is responsible for receptor binding (von Eichel-Streiber et at., 
1992). 
The mode of action of toxins A and B have been extensively studied and shown to 
be functionally similar. They are both endocytosed by the host cell and target the 
Ras super family of GTPases for modification via glycosylation. Both toxin A and B 
of C. difficile act by causing rearrangement and disruption of the actin cytoskeleton 
through monoglucosylation of small Ras-like GTP binding-proteins Rho, Rac and 
Cdc42 (Just et al., 1994; 1995). The disruption of the actin cytoskeleton and tight 
junctions results in excessive fluid accumulation and destruction of the intestinal 
epithelium (Thelestam and Chaves-Olarte, 2000; Poxton, et al., 2001; Voth and 
Ballard, 2005; Rupnik, et al., 2009). 
In the hamster animal model, the two toxins are thought to exhibit distinct effects; 
hence, TcdA is occasionally referred to as an 'entertoxin' and TcdB as a 'cytotoxin' 
(Lyerly et at., 1985; Kim et al., 1987; Boriello and Barclay, 1985). 
Previously, it was generally accepted that toxin A was the principal virulence factor 
responsible for CDAD. Yet, a recent study concluded that toxin B is required for 
disease in Golden Syrian hamsters (Lyras, et al., 2009). However, further research 
into this area is clearly needed, as data from our laboratory indicates that both toxin 
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A and toxin B alone are sufficient for disease in the hamster model (Kuehne, et al., 
2010). 
It has also been shown in the past that some C. difficile types also produce an actin-
specific ADP-ribosylating toxin, a binary toxin encoded by cdtA-cdtB (Carter, et at., 
2007; Rupnik, et al., 2009). Interestingly, this binary toxin is produced by all 
emerging C. difficile types that have been associated with outbreaks of increased 
disease severity, and it has been suggested that this toxin induces morphological 
changes in host intestinal epithelial cells, which facilitates increased adherence of 
these C. difficile types (Schwan, et al., 2009). 
The amount of toxin produced by different toxigenic strains varies and is thought to 
be highly influenced by environmental conditions. In the laboratory, toxin 
expression is at its maximum when cells enter stationary phase and is reliant on 
growth temperature (Hundsberger et aI., 1997; Dupuy and Sonenshein, 1998; 
Karrisson et al., 2003). Other factors also influence toxin expression such as the 
presence of certain amino acids in the growth media, butyric acid and butanol, and 
also carbon sources that are rapidly metabolised (Karlsson et al., 1999; Yamakawa et 
al., 1994; Karlsson et aI., 2000; Dupuy and Sonenshein, 1998). It has also been 
observed that addition of certain antibiotics and growth-limiting levels of the vitamin 
biotin also stimulate toxin production (Nakamura et ai., 1982; Yamakawa et ai., 
1996). 
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The toxin genes (tcdA and tcdB) along with three accessory genes (tcdR, tcdE and 
tcdC) are encoded within a 19.6kb chromosomal unit called the pathogenicity locus 
(PaLoc) (Cohen et at., 2000) (Figure 1.3). TcdR is an alternative RNA polymerase (J 
factor that activates toxin gene expression (Mani and Dupuy, 2001). It is thought that 
toxin expression is negatively regulated by TcdC (Matamouros et at., 2007). This 
notion first arose when it was observed that tcdC is highly expressing during rapid 
exponential growth but repressed in stationary phase when toxin expression is at its 
maximum (Govind et at., 2006; Hundsberger et at., 1997). 
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Figure 1.3 Genetic organisation of the C. difficile pathogenicity locus (PaLoc). 
Taken from Matamorous et at., 2007 
The variation in the severity of CDAD has been attributed to the level of toxin 
produced by the infecting strain of C. difficile (Borriello, 1990). However, there is 
little knowledge known of the exact molecular mechanism that play key roles in the 
disease process. For example, regulation of the factors that causes an increase in 
toxin synthesis are' poorly understood. In other bacterial pathogens quorum sensing 
(QS) plays a central role in the regulation of virulence factors. 
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1.3 Quorum Sensing in Bacterial Pathogens 
1.3.1 The principle of quorum sensing 
Quorum sensing describes a form of cell-cell communication among bacteria (Lerat 
& Moran, 2004). It is utilised by bacterial populations as a means of co-ordinately 
responding to external stimuli in a cell density-dependent manner. Quorum sensing 
occurs via signalling molecules known as autoinducers, and results in the regulation 
of specific genes (Fuqua et al., 1994). These signal molecules are released so that 
bacteria can detect the density of a popUlation in a particular environment. The 
molecules are released during growth and accumulate in the environment. Once the 
concentration of the signal molecule reaches a threshold, or 'quorum', this triggers a 
response in the bacterial population (Winzer et al., 2003). This usually involves a 
cascade of events which ultimately leads to changes in gene regulation (Winzer et 
al., 2003). Genes regulated by quorum sensing include those involved in virulence 
(Winzer et al., 2003), cell migration, formation of biofilms (Lerat & Moran, 2004), 
sporulation, and the production of toxins (Kleerebezem & Quadri, 2001). 
It may be favourable for individual bacterial cells to suppress the expression of 
certain genes when the popUlation density falls below a threshold. Synchronising the 
expression of virulence factors, once a minimal cell population density has been 
achieved enables a "united attack" against the host (Dong et al., 2005). This type of 
multicellular coordination is vital for the successful colonisation/infection of the host 
by many pathogenic bacteria (Williams et al., 2000; Swift et al., 2001; Camara et al., 
2002). 
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Quorum sensing was first described in the regulation of bioluminescence in Vibrio 
jischeri and Vibrio harveyi (Nealson et al., 1970; Nealson and Hastings, 1979). This 
Gram-negative bacterium Vibrio jischeri lives on marine eukaryotes and produces 
light for its hosts. Light emission only occurs when the bacterial cell density reaches 
a threshold, and the luciferase operon is transcribed. The autoinducer molecule is an 
acylated homoserine lactone (AHL) (Lerat & Moran, 2004). AHLs accumulate, and 
once a threshold is reached, activate a transcriptional regulator of the LuxR family 
(Winzer et al., 2003). 
Vibrio harveyi is another marine bacterium whose luminescence is regulated by 
quorum sensing. However, this organism has two quorum sensing systems and 
produces two auto inducers; auto inducer 1 (AI-I) and autoinducer 2 (AI-2) (Bassler 
et al., 1993). The first quorum sensing system is similar to that of Vibrio jischeri and 
uses an AHL signal molecule; however AI-l production is not reliant on a LuxI-type 
molecule but instead is produced by the luxLMlocus (Bassler et al., 1993). The 
second system relies on the accumulation of a molecule called auto inducer 2 (AI -2), 
which is believed to be a furanosyl borate diester (Chen et al., 2002). AI-2 is 
generated via the LuxS enzyme (Schauder et al., 2001). AI-l is sensed by the 
periplasmic protein LuxN. AI-2 binds to the periplasmic protein LuxP which then 
interacts with a membrane-bound histidine protein kinase, LuxQ. A series of 
dephosphorylation reactions are commenced resulting in the transduction of 
information to a shared integrator protein, LuxU. In tum, LuxU sends a signal to the 
response regulator protein LuxO, a cr54 -dependent transcriptional activator. The 
function of LuxO is to control the transcription of a putative repressor protein and a 
transcriptional activator protein called LuxR, which is required for the expression of 
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the luciferase operon (/uxCDABE) (Bassler et al., 1993). Once the signal has been 
passed to LuxO, it can no longer activate transcription of the repressor gene, and 
therefore the lux operon is consequently transcribed (Winzer et al., 2003). 
1.3.2 LuxS/AI-2 quorum sensing systems 
A variety of Gram-positive and Gram-negative bacteria possess luxS homologues, 
similar to those found in V. harveyi (Winzer et al., 2003). In fact, it has been claimed 
that BLAST searches have shown evidence of luxS homologues in the genomes of 
'most bacterial species for which complete sequence data are available' (Hilgers & 
Ludwig, 2001). In addition, Xavier and Bassler (2003) found that the luxS gene 
exists in 35 of the 89 currently available complete bacterial genomes by database 
analysis. peR, along with AI-2 activity assays, have allowed the identification of 
luxS in a number of species for which no genome sequences are available (Xavier & 
Bassler, 2003). 
In some cases, signalling molecules can be recognised by different bacterial species. 
This is known as interspecies cross-talk and can either promote or inhibit gene 
expression (SturIne et al., 2002). As luxS homologues have been found in many 
different bacteria, it has recently been proposed that AI-2 could serve as a 'universal 
signal' for interspecies cross-talk (Xavier & Bassler, 2003). However, this is yet to 
be proven in species other than Vibrio. 
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Despite the proposed role of LuxS in quorum sensing, it is speculated that LuxS is in 
fact a metabolic side product produced during the activated methyl cycle (a recycling 
pathway involved in the metabolism of methionine) (Winzer et al., 2003). Indeed, 
Doherty et al. (2006) demonstrated that the inactivation of luxS in Staphylococcus 
aureus had no effect on virulence-associated traits. It is possible that the phenotypic 
changes observed in some bacteria following inactivation of luxS, may be due to the 
absence of the AI-2 signal molecule, but they could also be attributed to the 
disruption of the activated methyl cycle (Winzer et al., 2003). 
1.3.3 Quorum sensing in Gram-positive bacteria 
Quorum sensing in Gram-positive bacteria occurs via a range of different signals but 
all systems involve a two-component regulatory signal transduction system, 
consisting of a membrane-bound receptor histidine protein kinase, and an 
intracellular response regulator (Sturme et al., 2002). When the response regulator is 
phosphorylated by the receptor kinase, transcription of target genes is activated or 
repressed. Transcription of genes involved in the production of the autoinducing 
peptides is also activated (Sturme et al., 2002). Most Gram-positive bacteria use 
signalling molecules that are created from large precursors and post-translationally 
modified (Fuqua & Greenberg, 1998). They are then exported using ATP binding 
cassette (ABC) export systems (van der Meer et al., 1993). Some bind to sensor 
kinases in the cell membrane, which transduce the signal across the membrane. 
Others bind to intracellular receptors after being transported into the cell by 
oligopeptide permeases. 
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1.3.4 The agr system of Staphylococcus aureus 
In S. aureus the accessory gene regulator (agr) system regulates the temporal 
expression of cell-surface colonisation factors and exoproteins, which contribute to 
virulence (Novick and Muir, 1999). This is the only known quorum sensing system 
in the staphylococci (Kies et al., 2003) and was first identified in S. aureus. The 
expression of many secreted virulence factors is up-regulated by the agr system in 
the transition from late-exponential growth to stationary phase, whereas the 
expression of the surface proteins, for example fibronectin binding proteins A and B, 
is down-regulated (li et al., 1995, Lyon et al., 2000; Novick et at., 1993; Yarwood & 
Schlievert, 2003). The system is able to switch on in the later parts of the growth 
phase by sensing the cell density of its surroundings (Otto et al., 1998). The 
virulence factors controlled by the agr system include a, p and 8 cytotoxins 
(haemolysins), serine protease, DNase, fibrinolysin, enterotoxins A-D, toxic shock 
syndrome (TSS) toxin 1 (Otto et al., 1998), and leucocidins (Novick et aI., 2008). 
Other proteins whose production is regulated by the agr system in staphylococci 
include staphopain, lipase, phospholipase C, nuclease, hyaluronidase, coagulase, 
protein A (Novick, 2003), arginase, peptidase and chitinase B (Dunman et al., 2001). 
In addition, the agr system is also involved in the invasion and apoptosis of 
epithelial cells (Yarwood & Schlievert, 2003). 
The agr locus is approximately 3.5 Kb consists of two divergent operons, RNAII and 
RNAIII, which are transcribed from neighbouring but non-overlapping promoters, 
P2 and P3 respectively. The P2 operon contains four open reading frames agrA, 
agrC, agrD, and agrE, of which agrA and agrC form a two-component system for 
signal transduction (Novick et al., 1995). The P3 generated transcript, RNAIII, is the 
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actual intracellular effector of the agr response and controls the expression of target 
genes (Novick et at., 1993). It also encodes staphylococcal () toxin (Janzon and 
Arvind, 1990; Novick et at., 1995). The P2 operon is doubly autocatalytic since 
transcription of P2 requires P2 operon products, and is therefore suited to the need 
for rapid expression of exoproteins required when overall growth is coming to a halt 
(Morfeldt et at., 1988). 
The roles of the components of the agr system are outlined below and illustrated in 
Figure 1.4. 
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Figure 1.4. A schematic diagram of the agr quorum sensing system in Staphylococcus 
aureus taken from Chan et al. (2004). The AgrD propeptide is modified and secreted from 
the cell by AgrB and possibly another peptidase. This results in the formation of the mature 
AlP, which binds to the AgrC sensor kinase. Subsequent phosphorylation of AgrC activates 
the AgrA response regulator which promotes transcription of the agrBDCA operon. It also 
increases transcription of RNAIlI, the effector molecule of the system. 
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AgrC is the transmembrane sensor kinase of a two-component system, whose N 
terminal interacts with a signal molecule (Lina et at., 1998). Activation of AgrC then 
occurs via a phosphorylation event. It was originally proposed that the C-terminal 
was autophosphorylated at a histidine residue when stimulated by the signal 
molecule (Ji et al., 1995; Novick et al., 1995). However, subsequent investigations 
have found that AgrC is partially phosphorylated in the absence of any AlP. It has 
been suggested that the cytoplasmic domain of AgrC is dimeric, containing a four-
helix bundle, and that autophosphorylation would occur as a trans process (Novick, 
2003). 
AgrA is the response regulator, which is required for the activation of the P2 and P3 
promoters and is phosphorylated by AgrC. It binds with high affinity to the RNAIII-
agr intergenic region, with this binding being localised to a pair of direct repeats in 
the P2 and P3 promoter regions (Koenig et al., 2004). 
AgrD is the propeptide, which is synthesised within the cell, processed and then 
secreted. The agr-activating ligand is a post-translationally modified peptide (auto-
inducing peptide-AlP) which is processed from a pre-peptide encoded by agrD. The 
transmembrane protein, AgrB, is involved in processing of the pre-peptide, and 
secretion of the post-translationally modified auto-inducing peptide (AlP) (Ji et al., 
1995). The AgrD protein is processed at both the N - and C-terminal ends. A 
cyclisation reaction occurs, where a thioester linkage is formed between a conserved 
cysteine residue and the C terminal carboxyl group, in order to form the mature 
thiolactone AlP (Novick, 2003; Lyon and Novick, 2004). 
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AgrB is a transmembrane protein essential for the generation and secretion of the 
AIP. In S. aureus the peptide export system is not an ABC transporter, and it has 
been suggested that this function may be carried out by AgrB (Sturme et al., 2002). 
It is also required for the proteolytic modification of AgrD (Yarwood & Schlievert, 
2003). This modification of AgrD results in the production and secretion of the AlP 
(Zhang et at., 2004) 
AlP, the autoinducing peptide of the two-component system, is a cyclic thiolactone 
of seven to nine amino acids, and is crucial for agr activity (Zhang et at., 2002). The 
agr genes are constitutively expressed at low cell densities, but when the AlP level 
reaches a threshold, the agr response is activated (Ji et at., 1995). The signalling 
transduction cascade produced by the AgrA and AgrC two component system results 
in an increase in the transcription of RNAII and RNAIII in a positive feedback 
manner (Yarwood & Schlievert, 2003). 
Signal molecules produced by the agr system in S. aureus have been shown to 
stimulate agr activation in cells of their own population, but to inhibit expression of 
the agr system in cells of a different population (Kies et at., 2003). This is largely 
due to the fact that variations in specific regions of agrB, agrD and agrC have 
resulted in the allocation of four agr specificity groups in S. aureus (Novick, 2003). 
The groups were determined by assessing the ability of their AIP molecules to 
inhibit the agr response in other groups (Ji et al., 1997). These AIP groups show 
extremely high specificity, and just a single amino acid change can transform the 
AIP to a different group (Novick, 2003). Cross inhibition occurs across these four 
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AlP groups, but the AlPs from groups I and IV are able to activate each other's agr 
system due to their strong similarity (Chan et al., 2004). The structures of the AlPs 
from the four S. aureus agr groups are illustrated in Figure 1.5. 
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Figure 1.5 - Structures of the AlPs from the four S. aureus agr groups. Letters refer to 
amino acid residues. Exocyclic tail residues are shown in grey; endocyclic residues are 
shown in white. Taken from Lyon et al. (2002). 
RNAIII has two functions. It encodes the 0 haemolysin toxin via the hld gene, but is 
also responsible for the increase in transcription of extracellular virulence factors, 
such as toxins, and the decrease in transcription of cell surface proteins (Yarwood & 
Schlievert, 2003). It has been demonstrated that RNAIII exerts these effects by its 3' 
domain acting as an antisense RNA, and repressing translation of mRNAs encoding 
virulence factors acting early in the infection process (Boisset et ai., 2007). In 
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addition, the increase in transcription of secreted virulence factors observed in the 
later stages of infection was shown to occur by the antisense down-regulation of Rot 
(repressor of toxins) mRNA by RNAIII. Since Rot has been identified as an 
antagonist to the agr response, this de-repression permits the translation of many of 
the secreted virulence factors associated with the later stages of infection. It has also 
been demonstrated that the 3' domain of RNAIII by itself is able to promote the 
synthesis of several exoproteases and exotoxins (Boisset et ai., 2007). 
The production of RNAIII is affected by a second regulatory system - the 
staphylococcal accessory regulator sar (Blevins et ai., 2002). Indeed, Blevins et at. 
(2002), Bayer et ai. (1996) and Dunman et ai. (2001) all demonstrated that mutating 
sarA resulted in a decrease in the production of RNAIII. Binding of SarA to the P2 
and P3 promoters promotes transcription of RNAII and RNAIII, indirectly affecting 
virulence factor regulation. The sar locus also operates independently of agr, 
regulating other virulence factors directly (Dunman et al., 2001). 
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1.3.5 Molecular studies on the agr system 
Mutation of the agr system has been shown to have a number of effects. The 
expression of exotoxins such as a, ~ ~ and 0 toxins, serine protease, DNase, 
fibrinolysin, enterotoxin Band TSS toxin 1 has been shown to decrease, hence 
reducing virulence. An increase was also seen in the expression of many surface 
proteins (Recsei et aI., 1986). 
Mutation of agr has also been shown to inhibit proteolytic, lipolytic and haemolytic 
activity in S. aureus (Blevins et al., 2002). Kies et al. (2003) demonstrated that 
production of the antibiotic epidermin in a S. epidermidis agr mutant was strongly 
reduced compared to the wild type, showing that the agr system plays an important 
role in epidermin biosynthesis. 
The agr system therefore has potential for targeting III an attempt to attenuate 
virulence in staphylococci. However, there is an alternative argument that 
inactivating the agr system may, in fact, contribute to the conversion of an acute 
infection to a chronic one (Kong et al., 2006). Some studies have shown that 
inhibiting the agr system enables staphylococci to form biofilms more readily. 
Vuong et al. (2004) demonstrated this in S. epidermidis and suggested that this may 
present problems when using medical implant devices. 
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1.3.6 Agr in clostridia 
During this study, sequence alignments show that homologues of the agr genes 
occur in a number of bacteria besides staphylococci. In particular, they have been 
found in various clostridial species such as C. perjringens, C. botulinum, C. 
acetobutylicum, C. sporogenes and C. difficile (see Figure 1.6). agr homologues 
have also been found in Listeria monocytogenes (Autret et al., 2003), Lactobacillus 
plantarum (Diep et al., 1994) and Enterococcus faecalis (Nakayama et at., 2001). 
The availability of completed genome sequences and mutagenesis tools have enabled 
functional genetic analysis of agr in clostridia to take place and recently the role of 
agr in C. perfringens and C. botulinum has been reported (Othani et al., 2009; 
Cooksley et al., 2010). 
The work of Othani et al. has shown that in C. perfringens strain 13, agr plays a role 
in the regulation of toxin expression. In a C. perfringens agrBD mutant strain, 8 
toxin gene expression was abolished and transcription of both a and p toxin genes 
was decreased. Toxin expression in the mutant strain was restored by the addition of 
wild type culture supernatant (Othani et al., 2009). 
The virRlvirS two component system has been shown to regulate toxin gene 
expression in C. perfringens (Shimizu et al., 1994). However the signal detected by 
VirS and how the signalling system stimulates toxin expression was unknown. 
Therefore role· of the VirRlVirS in agrBD-mediated toxin regulation was 
investigated in C. perfringens strain 13. Addition of wild type culture supernatant to 
an agrlvirR mutant strain did not restore toxin production. This indicates that the 
signal peptide produced and processed by agrD and agrB respectively, is detected by 
the ViRlVirS two component system and subsequently transcription of the toxin 
genes activated (Othani et ai., 2009). 
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Figure 1.6 - Schematic diagram showing agr gene regions in four species of clostridia. The different colours represent homologous genes. White genes do not show 
any homology. 
In the genome sequence of C. botulinum group I strains, there are two agr loci both 
of which contain homologues of the S. aureus agr genes, agrB and agrD. Both 
sporulation and neurotoxin production were drastically reduced in the agrD mutant 
strains of C. botulinum (Cooksley et ai., 2010). It is reported that the two agr loci in 
C. botulinum plays two different roles; the first agr loci, agr 1, regulates sporulation 
and the second agr loci, agr2, regulates neurotoxin production. To date, this is the 
first report of a putative quorum sensing system shown to be involved in the 
regulation of sporulation in clostridia. 
1.4 Project aims 
An unannotated open reading frame (ORP) which shares homology with the agrD 
gene of S. aureus, has been discovered in the genome sequence of C. difficile. C. 
botulinum and C. perfringens also contain an agrD homologue equivalent to the 
agrD gene of C. difficile as illustrated in Figure 1.6. As with S. aureus agrD, all 
three clostridial agrD genes are preceeded by an agrB homologue. It has recently 
been reported that agr plays a role in the regulation of toxin production in C. 
perfringens and neurotoxin and sporulation in C. botulinum (Othani et al., 2009; 
Cooks ley et ai., 2010). As agr homologues are also found in the genome sequence of 
C. difficile, this study sets out to discover whether the expression of virulence factors 
are under the control of an agr-QS based regulatory system. The hypothesis that the 
agr system in C. difficile controls virulence factor production through a quorum 
sensing mechanism was tested by making insertional mutants of agrB and other agr 
homologues in C. difficile and the effects on virulence were assessed, paymg 
particUlar attention to toxin production and sporulation in the first instance. 
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In many pathogenic bacteria quorum sensing controls the regulation of so many 
processes, including the production of virulence factors in some clostridia species. 
Therefore, it is a focus for attention as a therapeutic target in the search for 
alternatives to conventional antibiotic therapy, which is becoming increasingly 
redundant due to the emergence of resistance. 
Characterisation of a putative QS system in C. difficile could provide identification 
of previously unknown factors that participate in the progression of CDAD. 
Identification of such factors may lead to the generation of much needed novel 
therapeutic drugs (such as AlP blockers) that interfere with quorum sensing. 
Targeting the QS signalling pathway or the virulence factors that are discovered to 
be under its control is a promising therapeutic approach for the treatment of CDAD 
supportive of primary antibiotic therapy. 
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Chapter 2 
Materials and Methods 
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2.1 Bacteriological methods 
2.1.1 Bacterial strains 
The bacterial strains used in this study are listed in Table 2.1. Clostridium difficile 
strains were stored at -800 , as a mixture of spores and vegetative cells resuspended in 
brain heart infusion (BHIS) broth, supplemented with 20% (v/v) glycerol. 
Strain 
Escherichia coli TOP 10 
E. coli CA434 
C. difficile 630Mrm 
C. difficile R20291 
C. difficile 6 3 0 ~ e r m m
agrB: :CTermB 
C. difficile 6 3 0 ~ e r m m
CDO 160: :CT ermB 
C. difficile 6 3 0 ~ e r m m
CD0611 : :CT ermB 
C. difficile 6 3 0 ~ e r m m
CDl743::CTermB 
C. difficile 6 3 0 ~ e r m m
luxS::CTermB 
C. difficile R2029 I 
agrBI ::CTermB 
C. difficile R20291 
agrB2::CTermB 
C. difficile R20291 
agrA::CTermB 
C. difficile R20291' 
luxS: :CTermB 
Relevant properties 
F- mcrA ~ ( m r r - h s d R M S - m c r B C ) ) < I > 8 0 I a c Z ~ M 1 5 5
~ / a c X 7 4 4 recAl araD139 ~ ( a r a a leu) 
7697 galU ga/K rpsL (StrR) endAl nupG 
Conjugation donor 
PCR-ribotype 012 
Erythromycin sensitive strain of 
C. difficile 630 
BIINAPlI027 (Stoke Mandeville, UK). Isolated 
in 2004/5 
C. difficile 6 3 0 ~ e r m m agrB insertional mutant 
made using ClosTron 
C. difficile 6 3 0 ~ e r m m CDOl60 insertional mutant 
made using the ClosTron 
C. difficile 630Mrm CD0611 insertional mutant 
made using the ClosTron 
C. difficile 6 3 0 ~ e r m m CDl743 insertional mutant 
made using the ClosTron 
C. difficile 6 3 0 ~ e r m m luxS insertional mutant made 
using the ClosTron 
C. difficile R20291 agrBl insertional mutant 
made using the ClosTron 
C. difficile R20291 agrB2 insertional mutant 
made using the ClosTron 
C. difficile R20291 agrA insertional mutant made 
using the ClosTron 
C. difficile R202911uxS insertional mutant made 
using the ClosTron 
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Source/reference 
Invitrogen 
Purdy et al., 
2002 
Hussain et al., 
2005 
Anaerobe 
Reference 
L i b r a r y , C a r d i f ~ ~
United Kingdom 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
C. dijficile R20291 
CD2603: :CT ermB 
C. dijficile 630L1erm 
spoOA: :CT ermB 
C. dijficile R20291 
spoOA: :CT ermB 
C. dijficile 630L1erm 
agrB: :CTermB 
(pMTL84151: :agrBD 1) 
C. dijficile 630L1erm 
agrB: :CTermB 
(pMTL84151 ) 
C. dijficile 630L1erm 
(pMTL84151 ) 
C. dijficile R20291 
agrB1 ::CTermB 
(pMTL84151 : :agrBD 1) 
C. dijficile R20291 
agrB1::CTermB 
(pMTL84151 ) 
C. dijficile R20291 
(pMTL84151 ) 
C. dijficile R20291 
agrB2::CTermB 
(pMTL84151 ::agr2) 
C. dijficile R20291 
agrB2::CTermB 
(pMTL84151 ) 
C. dijficile R20291 
agrA::CTermB 
(pMTL84151::agr2) 
C. dijficile R20291 
agrA::CTermB 
(pMTL84151 ) 
C. dijficile 630 L1erm 
(pMTL84151 ::agr2) 
C. dijficile R20291 CD2603 insertional mutant 
made using the ClosTron 
C. dijficile 630i1erm spoOA insertional mutant 
made using the ClosTron 
C. dijficile R20291 spoOA insertional mutant 
made using the ClosTron 
C. dijficile 630i1erm agrB insertional mutant 
containing agrBD1 complementation plasmid 
C. dijficile 630L1erm agrB insertional mutant 
containing pMTL84151 
C. dijficile 630L1erm containing pMTL84151 
C. dijficile R20291 agrB1 insertional mutant 
containing agrBD 1 complementation plasmid 
C. dijficile R20291 agrB1 insertional mutant 
containing pMTL84151 
C. difficile R20291 containing pMTL84151 
C. difficile R20291 agrB2 insertional mutant 
containing agr2 complementation plasmid 
C. difficile R20291 agrB2 insertional mutant 
containing pMTL84151 
C. difficile R20291 agrA insertional mutant 
containing agr2 complementation plasmid 
C. difficile R20291 agrA insertional mutant 
containing pMTL84151 
C. difficile 630L1erm containing 
pMTL84151: :agr2 
Table 2.1. Bacterial strains used in this study. 
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This study 
Heap et al., 2007 
Heap et al., 2010 
This study 
This study 
Bums et al., 2010 
This study 
This study 
Bums et aI., 2010 
This study 
This study 
This study 
This study 
This study 
2.1.2 Plasmids 
All plasmids used in this study are listed in Table 2.2. 
Plasmid 
pMTL007C-E2 
pMTL007C-E2: :Cdi-agrB-
316s 
pMTL007C-E2: :Cdi-
CDO 160-246s 
pMTL007C-E2::Cdi-
CD0611-162s 
pMTL007C-E2: :Cdi-
CDi743-390s 
pMTL007C-E2: :Cdi-luxS-48s 
pMTL007C-E2: :Cdi-luxS-
l6la 
pMTL007C-E2: :CdiR2029l-
agrBl-362a 
pMTL007C-E2::CdiR20291-
agrB2-3l3a 
pMTL007C-E2::CdiR20291-
agrA-306s 
Relevant properties Source/reference 
ClosTron plasmid containing cafP and intron Heap et al., 2010 
containing ermB RAM 
pMTL007C-E2 retargeted to C. difficile agrB- This study 
3l6s 
pMTL007C-E2 retargeted to C. difficile This study 
6 3 0 ~ e r m m CD0160-246s 
pMTL007C-E2 retargeted to C. difficile This study 
6 3 0 ~ e r m m CD06ll-l62s 
pMTL007C-E2 retargeted to C. difficile This study 
6 3 0 ~ e r m m CDi743-390s 
pMTL007C-E2 retargeted to C. difficile luxS- This study 
48s 
pMTL007C-E2 retargeted to C. difficile luxS- This study 
l6la 
pMTL007C-E2 retargeted to C. difficile R20291 This study 
agrBl-362a 
pMTL007C-E2 retargeted to C. difficile R2029l This study 
agrB2-3l3a 
pMTL007C-E2 retargeted to C. difficile R2029l This study 
agrA-306s 
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pMTL84151 Clostridium modular plasmid containing catP Heap et al., 2009 
pMTL84151::agrBD1 pMTL84151 containing 806 bp agrBD coding This study 
region, a presumed 452 bp upstream promoter 
region and 152 bp downstream of the agrBD 
locus 
pMTL84151 : :agr2 pMTL84151 containing 2,915 bp agr2locus This study 
coding region, a presumed 400 bp upstream 
promoter region and 269 bp downstream of the 
agr2locus 
Table 2.2. List of plasmids used in this study. 
2.1.3 Routine culture of aerobic bacterial isolates 
Escherichia coli strains were routinely cultured on Luria Bertani (LB) broth or agar 
as appropriate. Cultures were incubated aerobically with shaking at 200 rpm at 37°C. 
The media was supplemented with chloramphenicol at 12.5 Jlg/ml (in broth) or 25 
Jlg/ml (in agar) where appropriate. E. coli TOPIO was used throughout as a cloning 
host and E. coli CA434 was used as a donor strain for transfer of plasmid DNA into 
C. difficile by conjugation. 
2.1.4 Routine culture of anaerobic bacterial isolates 
Unless stated otherwise, strains of Clostridium difficile were routinely cultured in 
BHIS (brain heart infusion supplemented with L-cysteine [0.1 %; Sigma, United 
Kingdom] and yeast extract [5 mg/ml; Oxoid] broth or agar; a medium that has been 
shown to aid C. difficile spore formation (Sorg and Sonenshein, 2008). Cultures were 
incubated at 37°C in an anaerobic workstation (Don Whitley, United Kingdom) 
containing an atmosphere of 80% (v/v) nitrogen, 10% (v/v) hydrogen and 10% (v/v) 
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carbon dioxide. The media was supplemented as appropriate with cycloserine (250 
Ilg/ml), cefoxitin (8 Ilg/ml), thiamphenicol (15 Ilg/ml), erythromycin (10 Ilg/ml) or 
lincomycin (20 Ilg/ml). Prior to inoculation, all growth media was pre-reduced 
overnight. 
2.1.5 Preparation of electro-competent E. coli cells 
A 200ml volume of pre-warmed LB broth was inoculated 1/100 with a fresh 
overnight culture of E. coli. The culture was incubated at 37°C with 200 rpm 
shaking until an optical density at 600 nm (OD600) of between 0.5 and 1 was 
achieved; indicating that the cells were in exponential growth phase. Cells were 
harvested by ali quoting the culture into 50ml falcon tubes, cooling on ice for 30 min, 
followed by centrifugation for 15 min at 4000 x g at 4°C. The cell pellets were gently 
re-suspended in 40 ml of ice-cold, sterile dH20 before centrifugation as described 
above. Resuspension of the cell pellets in ice-cold dH20 was repeated once again. 
Following centrifugation, the pellets were re-suspended in 4ml of sterile 10% 
glycerol and centrifuged as before. After discarding the supernatant, pellets were 
finally resuspended in 600 III of sterile 10% glycerol and stored at -80°C in 50 III 
aliquots. 
2.1.6 Measurement of C. difficile growth in BHIS broth 
To measure the growth rates of C. difJicile strains, cultures were set up in BHIS 
broth using a 1/100 inoculum of a fresh overnight culture and incubated at 37°C in 
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anaerobic conditions. At different time points, 0.5-1 ml samples were removed from 
the culture and the OD600 was measured. (Biomate 3, Thermo Scientific). 
2.1.7 Sporulation assays 
2.1.7.1 Preparation of C. difficile sporulation cultures in liquid media 
Sporulation of C. difficile in a nutrient-rich liquid medium was achieved by 
incubating cultures anaerobically in BHIS broth for five days at 37°C. To ensure 
that no spores were present when the sporulation medium was inoculated, a starter 
culture was prepared in BHIS broth using a 11100 inoculum of a C. difficile culture 
and incubated until an OD600 of between 0.2 and 0.5 was reached. The sporulation 
medium was then inoculated 111 00 with this exponential starter culture. 
2.1.7.2 Heat treatment of sporulation cultures 
Sporulating cultures of C. difficile were prepared as described above. A 500 III 
sample of the culture was removed from the anaerobic chamber and heated at 60°C 
for 30 minutes to kill the vegetative cells but not the spores. To control for any 
effects of oxygen exposure during heat treatment, a non-heated sample was also 
removed from the anaerobic chamber for 30 minutes. Heat-treated samples were 
then returned to the anaerobic chamber, serially diluted in PBS, and plated onto 
BHIS agar supplemented with 0.1 % taurocholate (Sigma, United Kingdom). Total 
cfulml (spores and vegetative cells) was also enumerated by serial dilution and 
plating onto BHIS agar supplemented with 0.1 % taurocholate before heat treatment. 
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After a 24 hour incubation period, bacterial colonies were counted at the appropriate 
dilution and cfulml were calculated by mUltiplying out the dilution factor. Samples 
were analysed in the same way every 24 h for five days. C. difficile spoOA mutants of 
both 6 3 0 ~ e r m m and R20291 were used as sporulation-negative controls (Heap, et al., 
2007; Heap, et al., 2010). 
2.2 Molecular Biology Methods 
2.2.1 Preparation of genomic DNA 
Genomic DNA was prepared using the DNeasy Blood & Tissue Kit (Qiagen) 
according to the instructions provided by the manufacturer. 
2.2.2 Preparation of plasmid DNA 
Plasmids were prepared using the Plasmid Miniprep Kit (Qiagen) according to the 
instructions provided by the manufacturer. 
2.2.3 Agarose gel electrophoresis 
A 1 % agarose gel was made by dissolving agarose powder in 1 X T AE buffer and 
ethidium bromide added to a final concentration of 0.5 ~ g / m l . . Once the gel had been 
cast, the gel tray was submerged in an electrophoresis tank containing 1 X T AE 
buffer. DNA samples were mixed 5:1 with a gel loading buffer and 1 0 - 1 5 ~ l l of each 
sample was loaded into individual wells. A DNA ladder (New England Biolabs) was 
60 
added to at least one well in the gel to act as a size marker. Gels were 
electrophoresed at 90V for 20-60 minutes, until DNA bands were suitably resolved. 
Subsequently, the gel was visualised over a UV trans-illuminator. 
2.2.4 Purification of DNA from agarose gels 
DNA bands were excised from agarose gels under ultra-violet light, and DNA was 
purified using the QIAquick Gel Extraction Kit (Qiagen) in accordance with the 
manufacturer's instructions. 
2.2.5 Purification of DNA from enzymatic reactions 
DNA fragments were purified using the QIAquick peR Purification Kit (Qiagen) 
according to the manufacturer's instructions. 
2.2.6 Digest of DNA with restriction endonucleases 
All DNA restriction enzymes (New England Biolabs) were used in the buffers and 
under the conditions recommended by the manufacturer. 
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2.2.7 Dephosphorylation of free DNA ends 
To remove 5' phosphate groups from linearised plasmid DNA fragments and prevent 
self-ligation, dephosphorylation reactions were carried out using Antarctic 
Phosphatase (New England Biolabs) in accordance with manufacturer's instructions. 
2.2.8 Ligation of linear DNA fragments 
Ligations were carried out in 10JlI volumes with the appropriate vector: insert ratio, 
1 JlI lOx ligase buffer and 1 U of T4 DNA ligase (Promega). Reactions were 
incubated at room temperature overnight. 
2.2.9 Nitrocellulose membrane dialysis of DNA after ligation 
Following ligation reactions, the products were dialysed through an 0.025 Jlm 
nitrocellulose membrane (Millipore) over dH20 for 30 minutes. The reaction 
mixture was then transformed into E. coli as required. 
2.2.10 Transformation of electro-competent E. coli by electroporation 
A 50 JlI aliquot of electro-competent E. coli cells was thawed on ice. Once thawed, 
DNA was added to the cells, gently mixed and then transferred into a cold 0.2 em 
gap electroporation cuvette (Biorad). A pulse applied across the cuvette using an 
electroporator with 2.5 kV voltage, 25 JlF capacitance and 200 .Q resistance. 
Immediately after, a 250 JlI aliquot of SOC medium (Invitrogen) was added to the 
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mixture. The transformation mixture was then transferred into a sterile microfuge 
tube and the cells were allowed to recover for 1 hour under aerobic conditions, with 
shaking at 200 rpm. The transformation mix was plated onto LB agar supplemented 
with appropriate antibiotics to select for transformants. Plates were incubated at 
37°C for 16 hours, under aerobic conditions. Colonies were screened to identify 
those harbouring the plasmid vector with the desired insert by restriction mapping 
and PCR. Cloned inserts were sequenced where necessary. 
2.2.11 Spectrophotometric quantification of DNA 
The concentration of DNA from preparations was measured using a nanodrop ND-
1000 spectrophotometer. The OD26o of the preparation was measured and DNA 
concentration calculated, given that with a 1 cm path, a 50 mg/ml solution of double-
stranded DNA has an OD26o of 1. 
2.2.12 Nucleotide sequencing and analysis of sequence data 
DNA sequencing reactions were carried out by Geneservice Ltd, Cambridge and 
Geneservice Ltd, Nottingham. Sequence data were assembled and analysed using 
were VectorNTI software (Invitrogen). 
2.2.13 Transfer of plasmid DNA into C. difficile by conjugation 
Conjugative transfer of plasmid DNA into C. difficile was carried out as described by 
Purdy et al., 2002. Briefly, both donor and recipient cells were grown to stationary 
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phase in overnight cultures. A Iml volume of donor cells was harvested by 
centrifugation at 4000 x g for 1 minute. The cell pellet was washed with phosphate-
buffered saline (PBS), in order to remove traces of antibiotics, and centrifuged as 
before. In an anaerobic workstation, the donor cell pellet was re-suspended in a 
suspension of recipient cells, yielding a suspension containing an approximate 5: 1 
ratio of donor to recipient cells. The donor-recipient suspension was then plated 
onto BHIS agar in discrete spots and incubated anaerobically at 37°C overnight. 
Cells taken off the plate by gently scraping with a loop and re-suspended into 500 ~ l l
PBS and subsequently plated onto media containing cycloserine (250 ~ g l m l ) , ,
cefoxitin (8 ~ g l m l ) , , thiamphenicol (15 ~ g l m l ) ) and lincomycin (20 ~ g l m l ) ) as 
appropriate to counter select against growth of E. coli donor strains and to positively 
select for C. difficile transformants. Plates were incubated anaerobically at 37°C for 
24-n h before colonies were picked and purified by subculture for further analysis. 
2.2.14 Amplification of DNA by polymerase chain reaction (peR) 
For cloning, PCR amplifications were carried out using either the Epicentre Failsafe 
PCR system with Failsafe Premix E (Cambio), or Phusion polymerase (New 
England Biolabs) according to manufacturer's instructions. For screening PCR, Taq 
DNA polymerase (Promega) was used, in accordance with the manufacturer's 
instructions. The following amplification conditions were used, unless stated 
otherwise; 1 cycle at 94°C for 3 minutes, 30 cycles of 94°C for 30 seconds, 50°C for 
30 seconds and noc for 1 minute 30 seconds, and 1 cycle of noc for 10 minutes. 
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Oligonucleotide 
Intron retargeting 
EBS Universal 
Cdi-agrB-316s-IBS 
Cdi-agrB-316s-EBS I d 
Sequence (5'- 3') 
CGAAATTAGAAACTTGCGTTCAGTAAAC 
AAAAAAGCTTATAATTATCCTTAAAATACAAATATGTGCGCCCAGATAGGGT 
G 
CAGATTGTACAAATGTGGTGATAACAGATAAGTCAAATATAGTAACTTACCTT 
TCTTTGT 
Cdi-agrB-316s-EBS2 TGAACGCAAGTTTCTAATTTCGGTTTATTTCCGATAGAGGAAAGTGTCT 
Cdi-CD 160-246s-IBS AAAAAAGCTTATAATT ATCCTT AGTAAGCATTATAGTGCGCCCAGATAGGGTG 
Cdi-CDl60-246s- CAGATTGTACAAA TGTGGTGATAACAGATAAGTCA TTATATTT AACTT ACCTT 
EBSld TCTTTGT 
Cdi-CDl60-246s-EBS2 TGAACGCAAGTTTCT AA TTTCGATTCTTACTCGAT AGAGGAAAGTGTCT 
Cdi-CD611-162s-IBS AAAAAAGCTT AT AA TT A TCCTT AAA TT ACT ACATAGTGCGCCCAGA T AGGGTG 
Cdi-CD611-162s- CAGATTGTACAAA TGTGGTGATAACAGAT AAGTCT ACATAGAT AACTTACCTT 
EBSld TCTTTGT 
Cdi-CD611-162s-EBS2 TGAACGCAAGTTTCTAATTTCGGTTTAATTCCGATAGAGGAAAGTGTCT 
Cdi-CDl743-390s-IBS AAAAAAGCTT AT AATTATCCTT AAGT AACT ATATCGTGCGCCCAGATAGGGTG 
Cdi-CD 1 743-390s- CAGATTGTACAAATGTGGTGATAACAGATAAGTCT ATATCACTAACTT ACCTT 
EBSld TCTTTGT 
Cdi-CD 1 743-390s- TGAACGCAAGTTTCTAA TTTCGA TTTT ACTTCGATAGAGGAAAGTGTCT 
EBS2 
Cdi-luxS-48s-IBS AAAAAAGCTTATAATTATCCTTAAAAGTCAAAGCTGTGCGCCCAGATAGGGT 
G 
Cdi-luxS-48s-EBSld CAGATTGTACAAA TGTGGTGAT AACAGATAAGTCAAAGCTCCTAACTT ACCTT 
TCTTTGT 
Cdi-luxS-48s-EBS2 TGAACGCAAGTTTCTAATTTCGGTTACTTTCCGAT AGAGGAAAGTGTCT 
Cdi-luxS-161 a-IBS AAAAAAGCTT ATAA TT ATCCTTATGCTCCAAACCGGTGCGCCCAGAT AGGGTG 
Cdi-luxS-16Ia-EBSld CAGATTGTACAAATGTGGTGATAACAGATAAGTCAAACCGTGTAACTTACCTT 
TCTTTGT 
Cdi-luxS-16Ia-EBS2 TGAACGCAAGTTTCTAATTTCGGTTGAGCATCGATAGAGGAAAGTGTCT 
Cdi027-agrB 1-362a-IBS AAAAAAGCTTATAATTATCCTTACAAATCCCAACCGTGCGCCCAGAT AGGGT 
G 
Cdi027-agrBI-362a- CAGA TTGT ACAAA TGTGGTGATAACAGAT AAGTCCCAACCCATAACTT ACCTT 
EBSld TCTTTGT 
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Cdi027-agrBI-362a- TGAACGCAAGTTTCT AA TTTCGATTATTTGTCGAT AGAGGAAAGTGTCT 
EBS2 
Cdi027-agrB2-313a-IBS AAAAAAGCTTATAA TT ATCCTT AAAT AACTACTTAGTGCGCCCAGATAGGGTG 
Cdi027-agrB2-313a- CAGA TTGTACAAA TGTGGTGATAACAGAT AAGTCTACTT ATAT AACTT ACCTT 
EBSld TCTTTGT 
Cdi027-agrB2-313a- TGAACGCAAGTTTCTAA TTTCGGTTTTATTCCGAT AGAGGAAAGTGTCT 
EBS2a 
Cdi027-agrA-306s-IBS AAAAAAGCTTATAA TI ATCCTT AAGGAACATAAGAGTGCGCCCAGATAGGGT 
G 
Cdi027-agrA-306s- CAGATTGTACAAAGTGGTGATAACAGATAAGTCATAAGAGATAACTTACCTT 
EBS 1 d TCTTIGT 
Cdi027-agrA-306s- TGAACGCAAGTTTCT AA TTTCGATTTTCCTTCGATAGAGGAAAGTGTCT 
EBS2 
ClosTron sequencing 
Spofdx]1 GATGTAGATAGGATAATAGAATCCATAGAAAATATAGG 
pMTL007_RI AGGGTATCCCCAGTTAGTGTTAAGTCTTGG 
Mutant screening 
agrB _126] GTT AA TAT AACCACCATGCTGTTT AT AGGTTTITT ATTTGG 
agrB _388_ R ATTGGGCACAGAACACAAATTCCAACC 
CDOl60 19 F GCGAAGGTAAAAAATCAGAGAGG 
CDOl60 279 R TCTCTAAATATCTATAAACTCCTATCTCATAACC 
CD061 U24] GTCTAGTATACAATCTAGAACACG 
CD0611 449 R GTTAATTTTCTTAGCTCACTTTTAAAGTAGAGG 
CDI743 273 F GATGCTTTTGAAGTAGATGC 
CDI743 550 R TGATTATATAACTACGATGACACC 
luxS 95 F AGTAACTAAATTTGACTTGAGATTTTTACAGCC 
luxS 262 R AACCAATCTTAACTGTITTGGCATCTACATCTCCCC 
agrB I (Cdi027L 238] TGTGTTA TTGTCCAATAAGACAATTITCAGG 
agrB 1 (Cdi027L568 _ R CTAACATCACAAAAATCCAAAACATGGCAAATGCGC 
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agrB2_213 _R 
agrA_234] 
agrA_506_R 
RT-PCR 
ptsI] 
CD2751 R 
CD2751 F 
agrD] 
CD2749 R 
CD2749 F 
CD2748 R 
CD2748 F 
CDR20291_3192] 
CDR20291 3191 R 
CDR20291 3191 F 
CDR20291_3190_R 
CDR20291 3190 F 
TGAGATTGTAGAAAGTGAAGATTTTGAAATATATAGATATGG 
TGTTAATGTACACTCTTTATAATTCCTAGCATGATAACCTCC 
GATTTAGACATATTAATTATGGACATACAAATGAAAACAATAAATGG 
CTGTTTCTATATAAGTAATAGAATCTATTTTAATTCGG 
TAGCTGATGATGTACTTAATATGGGTACTGC 
TTACTCTGCTTAAATCATTTAAATGTACTTTGTTATCTTCC 
AGAGATTTGTTTAGAAGCAGTTAATCAAAGTTATGAAGCGC 
ACCTATAAACAGCATGGTGGTTATATTAACTATGAAAGC 
TTGTGTTCTGTGTCCAATAGAACATAGGAGTAACCC 
TAGCTGACAAAATAGCAGTGCTAAGTGCCAATGAGCTAGC 
TAATAGTACCTGTCCTTGGATTATTCATCAGCC 
TGAACAGCTCCACCATTCACATCTAAAACGATATTATATCC 
TCAAGGTCCATGTGTAATAAAGAGAATAACTGGATGTGGAGCTGG 
AATAGTTATTGGTCCTTCATCACCTCTAACTACTGCATTGTACC 
TTGATAATGGGTTCTCCTGGTAAGGTTGTTAGAGAGC 
TCTTCTGGTGGGTCAAATAGTGGTATTTTATAGGC 
TTGTGGAAAGTGTATAGTTGGGGTTCCTTGTTCGGTAATAAATCCC 
TTCCTGTATCAATTCAAGTAATTCTTCTGGTAATATATGTATTGC 
AAGTAGTACGTCTACTCGTGAAGATTTATCAATTAGAAATATGC 
TACAATACCTAATTACAGGTAACTGGGAGATATATTCCACCTCCC 
ATGAAATTATGTTAGATATAGGCAAGGAGAAGC 
ATTCGATAATGTAGTTCATCATCACATATTCC 
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agrAJ 
agrCJ 
agrD2J 
agrB2J 
CDR20291 3186 R 
CDR20291 3186 F 
CDR20291 3185 R 
CDR20291 3185 F 
CDR20291 3184 R 
Complementation 
agrB 1_ F 1 (EcoRI) 
CDR20291 3190 FI 
(EcoRI) 
agrC _ R (XbaI) 
agrC _ F (XbaI) 
CDR20291 3186 R 
(BglII) 
TAGTAGAATCAATGAGTGGAAGTACTGTTATAGTAGATGGC 
TGATATTCCTATTACCATACATAGAAGAATCTTAATATTTGG 
AATGCAATTGAAGCATGTATGGATATAAATAATGAGC 
AACTTGCACTGTTTGCTGATAATACAGCTATCCC 
AGTGCAAGTTCTTGGGTAGCACATCAGGCAAAAGAGCC 
TCCTAGCATGATAACCTCCTGTGAACTGTCTTAAAGTGC 
ACCTCTTAGTGAAAGTGAGAAAAAGCATTATAGAAAGACTGTGC 
ACCTTAATACTACTCATATTTATGCCCCTCCTAGCCAATCC 
AAGAAATGAAATATTAGGTGATAGCAAAGCATCTGTAGATGC 
ATGCAACTACTCCATCTGTTAGGGTTAAATTTATATTATCCAGAGC 
TTGATATTATTGATTATAGAAGAGTTAAAGATGGTGTGC 
TTCCTAACCATCCTGCTATAGAATATGTATCCATTATAGG 
AAAAAAGAATTCATGTTTAGAAGCAGTAAAGCAAAATTATAGAGC 
AAAAAAGAATTCAGTTTGTCTTGAAGCAGTAAAACAGAATAGAAAAGC 
AGGTAAATTAAATTATGAAATTATGTTAGATATAGGCAAGGAGAAGC 
TCTATCATGAACTTCGTTTATATTTTCATAATTCC 
CATCAAGTATAATACTTTTAATAGTAATAGGG 
TATTGGATATATGTGTCCATCGTTGTATGAGATGG 
Table 2.3. List of oligonucleotides used in this study. Oligonucleotides were used as 
described in the text. 
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2.2.15 Inactivation of C. difficile genes 
Target genes were insertionally inactivated using the ClosTron system as previously 
described (Heap, et at., 2007), using the modular ClosTron plasmid pMTL007C-E2, 
described in Figure 2.1 (Heap, et at., 2010). 
ColEI 
C 8 ~ ~ pMTL007C-E2 
892 6bp 
Grp " 
intron 
~ . . . - - __ ermB } ermB-
Grpl intron RAM 
thlA promoter 
ClosTron 
Cartman et al (20 I 0) 
Figure 2.1. The second generation, modular ClosTron plasmid pMTL007C-E2 
(Cartman, et at., 2010; Heap, et al., 2010). This plasmid uses the strong fdx 
promoter to drive expression of the ClosTron (Heap, et al., 2007). Intron re-
targeting using the HindIII and BsrGI restriction sites replaces a lacZ' stuffer 
fragment with the 5' ex on and the region of the intron conferring target specificity, 
and allows for the re-targeted pMTL007C-E2 to be analysed by blue/white 
screening, PCR or restriction analysis. 
2.2.16 Construction of re-targeted pMTL007C-E2 
Target sites were identified and intron re-targeting PCR primers designed using a 
computer algorithm (Perutka, et at., 2004), available free-of-charge at 
http://www.clostron.com. A 353 bp PCR product containing modified IBS, EBSld 
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and EBS2 sequences, responsible for target specificity of the intron, were amplified 
and assembled using SOEing (splicing by overlap extension) PCR. The following 
cycling conditions were used; 1 cycle at 94°C for 30 seconds, 30 cycles of 94°C for 
15 seconds, 55°C for 30 seconds and noc for 30seconds, and 1 cycle at noc for 2 
minutes. The 353bp PCR product was cloned into the BsrGI and HindIII sites of 
plasmid pMTL007C-E2 in order to retarget the group II intron to the gene of interest. 
Primers Spofdx_Fl and pMTL007 _Rl were used to verify the sequence of the insert. 
Re-targeted introns were named in accordance with the previously published 
ClosTron nomenclature (Karberg, et al., 2001; Perutka, et al., 2004; Heap, et al., 
2007). For example, the intron on plasmid pMTL007C-E2::CdiR20291-agrA-306s 
has been retargeted to insert in the sense orientation after base 306 of the agrA open 
reading frame (ORF) of C. difficile R20291. Re-targeted pMTL007C-E2 vectors 
were initially analysed by blue/white screening, restriction analysis with Sac! or 
BglII and/or PCR using primer pair spofdx_Fl/pMTL007 _Rl. Vectors were then 
confirmed by sequencing. 
2.2.17 Synthesis of re-targeted pMTL007C-E2 
The advance of commercial DNA synthesis technology during this study allowed for 
the construction of re-targeted pMTL007C-E2 plasmids to he outsourced (DNA2.0, 
USA; Heap, et al., 2010). Target sites and peR primers were designed as described 
above, and the supplier synthesised and cloned the subsequent 353 bp fragment into 
pMTL007C-E2. The re-targeted vector was delivered, sequence-verified, ready for 
transfer into C. difficile. 
70 
2.2.18 Isolation and confirmation of C. difficile ClosTron mutants 
Re-targeted pMTL007C-E2 plasm ids were introduced into C. difficile by 
conjugation as described in section 2.2.13. Transconjugants were selected on media 
supplemented with cycloserine (250 /lg/ml) , cefoxitin (8 /lg/ml) and thiamphenicol 
(15 /lg/ml), and then serially sub-cultured to obtain pure clones. A loop-full of 
transconjugant cells was re-suspended in 500 /ll PBS, serially diluted as appropriate, 
and plated onto media supplemented with cycloserine (250 /lg/ml), cefoxitin (8 
/lg/ml) and either erythromycin (2.5 /lg/ml, C. difficile 6 3 0 ~ e r m ) ) or lincomycin (20 
/lg/ml, C. difficile R2029l), to select for integration of the ClosTron. Genomic DNA 
was extracted from erythromycin-resistant ( 6 3 0 ~ e r m ) ) or lincomycin-resistant 
(R2029l) clones at random and used in a PCR to amplify the intron-exon junction. 
One clone of each desired mutant was selected, and the intron site was verified by 
sequencing using the primers pairs EBS Universal, RAM_Rl and screening primers 
Rl and Fl. 
2.2.19 Complementation of a C. difficile agrB mutant with parental agrB 
For complementation studies of agrB mutant strains of C. difficile 6 3 0 ~ e r m m and C. 
difficile R2029 1 , a 806 bp fragment encompassing the agrBD structural genes and 5' 
non-coding region was cloned into the modular plasmid pMTL84l5l (Heap, et aI., 
2009) to generate plasmid pMTL84l5l::agrBD1. The 452 bp 5' non-coding region 
likely encompassing the agrBD promoter, the 806 bp region containing the agrBD 
structural genes and the 152 bp 3' non-coding region were amplified by PCR using 
oligonucleotide primer pairs agrBl_Fl/agrDl_Rl. The primers were designed to 
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allow subsequent cleavage of the fragment generated with EcoRVBglII. The cleaved 
fragment was subsequently ligated with plasmid pMTL84151 cut with EcoRI and 
BglII, which yielded plasmid pMTL84151 ::agrBD1. As the protein encoded by 
agrB is the same in C. difficile 6 3 0 ~ e r m m and R20291, only one plasmid 
(pMTL84151 : :agrBD 1) was constructed for use with both agrB mutants. Both the 
pMTL84151::agrBD1 complementation plasmid and a pMTML84151 empty vector 
control were then transferred into C. difficile by conjugation. 
2.2.20 Complementation of a C. difficile R20291 agrB2 and agrA mutants 
with the parental agr2 locus 
For complementation studies of agrB2 and agrA mutant strains of C. difficile 
R20291, a 2,915 bp fragment encompassing the agr2 structural genes and 5' and 3' 
non-coding region was cloned into the modular plasmid pMTL841 to generate 
plasmid pMTL84151::agr2. The 400 bp 5' non-coding region likely encompassing 
the agr2 promoter, the 2,915 bp region containing the agr2 structural genes and the 
269 bp 3' non-coding region were independently amplified by PCR using 
oligonucleotide prImer pairs and 
agrC_FICDR20291_3186_R, respectively. The primers were designed to allow 
subsequent cleavage of the two fragments generated with EcoRVXbaI and 
XbaVBglII, respectively. The two cleaved fragments were subsequently ligated with 
plasmid pMTL84151 cut with EcoRI and BglII, which yielded plasmid 
pMTL84151 ::agr2, in which the two fragments were inserted contiguously. Both the 
pMTL84151::agr2 complementation plasmid and a pMTML84151 empty vector 
control were then transferred into C. difficile R20291 by conjugation. 
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2.2.21 Preparation of total RNA from Clostridium difficile 
Under anaerobic conditions, a 5ml sample of C. difficile liquid culture was added to 
10ml RNA protect (Qiagen) and mixed by inverting. The C. difficilelRNA protect 
mixture was incubated at 37°C for 5 minutes and subsequently harvested by 
centrifugation at 4000 rpm for 10 minutes at room temperature. The supernatant was 
discarded and the cell pellet was resuspended in 2ml RNA pro solution (MP 
Biochemicals) in a fume hood. The cell suspension was transferred to a matrix tube 
and incubated on ice before being lysed in a ribolyser at 5000 rpm for 30 seconds. 
After the cell lysate had been centrifuged at 13000 rpm for 15 minutes at 4°C, the 
supernatant was added to a microfuge tube containing 300/l1 chloroform and mixed 
by vortexing for 10 seconds. The upper phase was transferred into a fresh microfuge 
tube containing 500/l1 100% ethanol, mixed by inverting and incubated at -20°C 
overnight to precipitate the RNA. 
Following incubation overnight, the sample was centrifuged at 13000 rpm for 15 
minutes at 4°C to pellet the RNA. Once the supernatant had been discarded, the 
RNA pellet was washed with 500/l1 70% ethanol and then centrifuged at 13000 rpm 
for 5 minutes at 4°C. The supernatant was discarded and the RNA pellet air dried at 
room temperature before being resuspended in 50/l1 DEPC treated water and 
subsequently stored at -80°C. 
2.2.22 Removal of contaminating genomic DNA from total RNA 
Contaminating genomic DNA was removed from RNA samples using TURBO 
DNase (Ambion). A 50/l1 aliquot of RNA was mixed with 2/l1 TURBO DNase, 2/l1 
73 
RNase inhibitor (Promega),2 JlI TUBRO DNase buffer and incubated for 30 minutes 
at 37°C. Following the incubation period, 2JlI TURBO DNase and 2JlI RNase 
inhibitor was added to the RNA sample and incubated for a further 30 minutes at 
2.2.23 Purification of DNase-treated RNA 
DNase treated RNA was purified using the RNeasy MinE lute Cleanup Kit (Qiagen) 
according to manufacturer's instruction. The volume of the RNA sample was 
adjusted to 100JlI using RNase-free water. A 250JlI aliquot of buffer RLT was added 
to the sample and mixed, followed by the addition of 250JlI absolute ethanol. The 
solution was mixed by pipetting before being applied to the spin column and 
centrifuged at 10000 rpm for 15 seconds. The spin column was placed in a new 
collection tube and 500JlI buffer RPE was added and centrifuged as before. The flow 
through was discarded and the column washed for a second time by addition of 
500JlI 80% ethanol before being centrifuged as previously. The column was placed 
in a new collection tube and centrifuged at 13000 rpm for a further 2 minutes to dry 
the column. The RNA was eluted from the column by adding 14JlI RNase-free water 
and after leaving the column to stand for 1 minute, the column was centrifuged for 
10000 rpm for 1 minute. RNA samples were stored at -80°C prior to use. 
2.2.24 One-step Reverse Transcriptase PCR (RT -PCR) 
All RNA samples were prepared according to 2.2.21 and DNase-treated and purified 
as described in 2.2.22 and 2.2.23 respectively. RT-PCR was carried out using One-
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Step RT-PCR kit (Qiagen) as described in manufacturer's instructions. The reaction 
mix was composed of 10/-11 5x Qiagen OneStep R T -PCR buffer, 2 /-11 dNTP mix 
(containing IOmM of each dNTP), 1 /-11 of each gene specific primer (IO/-1M), 2/-11 
Qiagen OneStep RT-PCR enzyme mix and l/-1g temple RNA. The volume was 
adjusted to 50/-11 using RNase-free water. All reactions were set up on ice to inhibit 
any enzymatic activity. The thermal cycler was pre-heated to 50°C before the 
samples were placed inside. The RT-PCR reaction was initiated with a reverse 
transcriptase step, 50°C for 30 minutes, followed by a DNA polymerase 
activation/reverse transcriptase inactivation step, 95°C for 15 minutes. A total of 40 
cycles of the following conditions were used for amplification; denaturation at 94°C 
for 1 minute, annealing at 60°C for 1 minute and elongation at 72°C for 1 minute 30 
seconds. The reaction was concluded after a final elongation step of noc for 10 
minutes. After amplification, RT-PCR products were visualised on an agarose gel as 
described in section 2.2.3 or stored at -20°C until required. 
2.3 In vitro methods 
2.3.1 Preparation and maintenance of Vero and HT29 cell mono layers 
The African green monkey kidney epithelial Vero cell line and the human colon 
adenocarcinoma grade II HT29 cell line were used for cytotoxicity assays in this 
study. Complete growth media used for Vero cells was Dulbecco's Modified Eagle 
Medium (DMEM) (Sigma), supplemented with 10% (v/v) heat inactivated foetal 
calf-serum (Si'gma), 2mM L-glutamine (Sigma) and penicillin-streptomycin (Sigma). 
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Complete growth media used for HT29 cells was McCoy's 5A medium (Invitrogen), 
supplemented with 2mM L-glutamine (Sigma) and penicillin-streptomycin (Sigma). 
Vero cells and HT29 cells were revived from storage by resuspending them in pre-
warmed (37°C) complete growth media to a density of 2 x 105 cells/m!. A 20ml 
volume of this cell suspension was used to seed a 75 cm2 tissue culture flask (Nunc). 
Cells were incubated at 37°C in 5% CO2 and passaged every 2-3 days, once 
monolayers reached confluence. To passage the cells, growth media was poured off, 
cells were washed with 5ml PBS twice and incubated with 5ml 1 x trypsin-EDTA 
(Sigma) at 37°C for 5-10 minutes. After incubation, a 5ml volume of the appropriate 
medium was added to cells and the cell suspension swirled around the flask to help 
dislodge any remaining attached cells. The resulting cell suspension was 
resuspended in fresh growth medium to a final density of 2 x 105 cells/m!. A 20ml 
volume of this cell suspension was used to seed each fresh 75 cm2 tissue culture 
flask. 
2.3.2 Cytotoxicity assays 
A tissue culture flask containing a 70 - 90% confluence monolayer ofVero or HT29 
cells was used to seed 96-well plates for cytotoxicity assays. Cells were dislodged 
from the flask using 1 x trypsin-EDTA as described in section 2.3.1. The cell 
suspension was transferred into a 20ml tube and centrifuged at 1000 x g for 15 
minutes at room temperature. After centrifugation, the cell pellet was resuspended in 
10ml of the appropriate medium. The reSUlting cell suspension was resuspended in fresh 
growth medium to a final density of 2 x 105 cells/ml. A 100,,!! of the diluted cell suspension 
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was used to seed the cells into each well of a 96-well plate. The plates were incubated for 
48 hours at 37"C in 5% CO2 
For cytotoxicity assays, C. difficile strains were grown in Tryptose yeast (TY) media 
(3% w/v bacto-tryptose, 2% w/v yeast extract, 0.1 % w/v sodium thioglycolate, 
adjusted to pH 7.4) under anaerobic conditions as described in section 2.1.4. A Sml 
culture of C. difficile was grown overnight and cell densities were standardised 
before centrifugation and filtration. Supernatants were diluted in a fourfold series 
and 20111 of the dilutions were added to onto the monolayers of vero cells and HT29 
cells pre-incubated in 96-well plates for 48 hours as described above. Cytotoxic 
effects on the cells were recorded after 24 hours. 
2.4 Statistical analysis 
All statistical analysis was carried out in GraphPad Prism, using Student's t-test with 
a p value cut off ofp <0.05. 
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Chapter 3 
Identification of a putative quorum sensing 
system in Clostridium difJicile 630 and its effect 
on sporulation and toxin production 
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3.1 Introduction 
3.1.1 Mutational studies in C. difJicile 
The lack of in-depth studies into the genetic basis of C. difficile quorum sensing-type 
gene regulation has been largely attributed to an absence of reliable genetic tools. In 
the past, targeted inactivation of C. difficile genes was limited to single-crossover 
mutations through homologous recombination of a replication-defective plasmid 
(O'Connor et al., 2006). However, single cross-over integrants such as these are 
genetically unstable, meaning they are able to revert back to the genetic and 
phenotypic status of the parent strain. More recently, the ClosTron, a facile directed 
mutagenesis system, has recently been developed (Heap, et al., 2007; Heap, et al., 
2010) and allows for reverse genetics studies in C. difficile through the creation of 
stable, insertional mutants. 
The system is based on a novel way to insertionally inactivate genes using group II 
intron (Karberg, et al., 2001). The mobile intron can be specifically targeted to a 
gene of interest by altering a small region of its sequence (350 bp) according to the 
rules of an algorithm developed by Perutka et al. (2004). The only other component 
required to mobilise the intron is the LtrA protein which is provided in trans. Within 
the group II intron is an antibiotic resistance gene, which is interrupted by a self-
splicing group I intron. This particular arrangement ensures that the antibiotic 
resistance gene will only be restored following integration of the group II intron and 
self-splicing of the group I intron. Therefore, antibiotic resistance will only be 
achieved as a consequence of the integration event. The ClosTron system is ideal to 
inactivate genes encoding homologues of proteins important in quorum sensing in 
79 
other gram positive bacteria, and thus presumed to be important in quorum sensing-
type gene regulation C. difficile. 
3.1.2 Previous knowledge of quorum sensing systems in clostridia 
The poor availability of tools to manipulate clostridia genetically has held back 
progress on the investigation of gene regulation in this genus. Prior to the beginning 
of this study, detailed studies of C. difficile quorum sensing systems, in particular 
agr quorum sensing, had not been reported. However, there were reports about the 
role of a Im:S-type quorum sensing system in other clostridia. These findings indicate 
that quorum sensing type systems have a functional role in clostridia. 
Ohtani et al. (2002) showed that the luxS gene is involved in the regulation of toxin 
production in C. perfringens via quorum sensing. C. perfringens luxS mutants 
exhibited reduced levels of cr, K and e toxins in comparison to the wild type strain. 
Toxin expression in the C. perfringens luxS mutant strains could be complemented 
with wild type culture supernatant and toxin production was restored. 
There have also been reports proposing a role of a LuxSI AI -2 type signalling system 
in C. difficile. Carter et al. (2005) demonstrated that the AI-2 signalling molecule is 
also produced by C. difficile. However, they suggested that AI-2 was not involved in 
the control of toxin production, as down-regulation of the luxS gene using antisense 
RNA did not cause a reduction in toxin production. Lee & Song (2005) also carried 
out a similar study into luxS and quorum sensing in C. difficile, and demonstrated an 
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up-regulation of toxin A mRNA production in response to exposure to AI-2-
containing C. difficile supernatant. However, they could not demonstrate a 
concomitant increase in the level of the toxin. Their data do suggest, however, that 
/uxS plays some role in the regulation of toxin production in C. difficile. 
During the course of this study, Othani et al., (2009) and Cooksley et al., (2010) 
reported a role of agr in C. perfringens and C. botulinum respectively. In C. 
perfringens strain 13, agr is involved in the regulation of toxin gene expression. In 
the C. perfringens agrBD mutant strain, e toxin gene expression was abolished and 
transcription of both a and ~ ~ toxin genes was decreased (Othani et al., 2009). 
The virRlvirS two component system has been shown to regulate toxin gene 
expression in C. perfringens (Shimizu et al., 1994). However the signal detected by 
VirS and how the signalling system stimulates toxin expression was unknown. 
Therefore role of the virRlvirS in agrBD-mediated toxin regulation was investigated 
in C. perfringens strain 13. Addition of wild type culture supernatant to an agr/virR 
mutant strain did not restore toxin production. This indicates that the signal peptide 
produced and processed by agrD and agrB respectively, is detected by the viRlvirS 
two component system and subsequently transcription of the toxin genes activated 
(Othani et al., 2009). 
In the genome sequence of C. botulinum group I strains, there are two agr loci both 
of which contain homologues of the S. aureus agr genes, agrB and agrD. Both 
sporulation and neurotoxin production were drastically reduced in the agrD mutant 
strains of C. botulinum (Cooksley et al., 2010). It is reported that the two agr loci in 
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C. botulinum plays two different roles; the first agr loci, agr 1, regulates sporulation 
and the second agr loci, agr2, regulates neurotoxin production. To date, this is the 
first report of a putative quorum sensing system shown to be involved in the 
regulation of sporulation in clostridia. However, to date, there are no reports of the 
role of an agr-QS based system in C. difficile. 
3.1.3 Aim of this study 
As a range of genetic tools are now available for studying C. difficile, the way has 
been opened to understand more thoroughly the role of agr in C. difficile QS-
mediated regulation of virulence factors. In many bacterial pathogens quorum 
sensing plays pivotal role in the coordinate expression of virulence factors, including 
the production of virulence factors in some clostridia species. In S. aureus expression 
of virulence factors is regulated by the accessory gene regulator (agr) locus of the 
quorum-sensing (QS) signalling pathway. Homologues of the S. aureus agrBD locus 
have been identified in the genome sequence of C. difficile 630. The work described 
in this chapter set out to characterise the putative agr system of C. difficile 630. The 
hypothesis that the agr system in C. difficile controls virulence factor production 
through a quorum sensing mechanism was tested by knocking out agrB and other 
putative quorum sensing homologues in C. difficile 630 and assessing the effects on 
virulence, paying particular attention to toxin production and sporulation in the first 
instance. 
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3.2 Results 
3.2.1 Identification of agrBD homologues in C. difficile 630 
An unannotated open reading frame (ORF) which shares homology with the agrD 
gene of S. aureus, was discovered during annotation of the C. difficile 630 genome 
sequence (Sebaihia et al., 2006). C. botulinum, C. acetobutylicum and C. perfringens 
also contain an agrD homologue equivalent to the agrD gene of C. difficile. As with 
S. aureus agrD, all four clostridial agrD genes are preceeded by an agrB homologue. 
In staphylococci in addition to agrBD, the agr locus also contains two additional 
genes; agrC and agrA encoding a histidine sensor kinase and its cognate response 
regulator. The two-component regulatory system that is made up of AgrC and AgrA 
is required for sensing the AIP signal and for activating the response regulator. 
Homologues of the entire agr locus are also found in C. acetobutylicum, Listeria 
monocytogenes, Lactobacillus plantarum (Sebaihia et al., 2007; Autret et al., 2003; 
Sturme et al., 2005). However, in C. difficile 630 there are no apparent agrCA 
homologues located adjacent to the agrBD homologues on the chromosome. 
To begin characterising the agr system of C. difficile, we decided to inactivate agrB 
(responsible for the maturation and export of the post-transcriptionally modified 
autoinducing peptide-AlP) in the first instance. In addition to inactivating agrB, we 
also decided to inactivate putative agrA homologues in C. difficile 630 in order to 
find a response regulator for the agrBD locus in the C. difficile 630 strain. 
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3.2.2 Identification of an agrA homologue in C. difficile strain 630 
AgrA from C. acetobutylicum was used in a BLASTP search against the C. difficile 
630 genome. The BLASTP results returned a list of eight orphan response 
regulators; a gene encoding a response regulator which is not flanked by a gene 
encoding a kinase. The eight orphan response regulators identified from the 
BLASTP search (CD3255, CD1089, CD2603, CD0611, CD1743, CDOI60, CD0339 
and CD2601) all belong to the LtyTR family of response regulators. The LytTR 
response regulator family is named after the LytT and LytR response regulators from 
Bacil/us subtilis and s. aureus, respectively. This family of response regulators is 
characterized by the presence of a novel DNA -binding domain, which shows little 
similarity to the helix-turn-helix or winged-helix domains that are more prevalent in 
other response regulators (Nikolskaya and Galperin, 2002). Members of the LytTR 
response regulator family include AgrA , the master regulator of the agr system in S. 
aureus (Morfeldt et al., 1996) and VirR, which controls the synthesis of several 
toxins in C. perfringens (Shimizu et al., 1994). 
From the eight orphan response regulators, two (CD3255 and CD 1089) had already 
been investigated by O'Connor and colleagues (2006). Microarray analysis indicated 
that CD1089 only reduced agrB expression by two-fold. We reasoned that if 
CD 1 089 was the master response regulator of the agr system, agrB expression levels 
would be reduced more substantially in CD1089, to a level of expression similar to 
that observed by S. aureus agr mutants (Abdelnour et ai, 1993; Gillaspy et al., 
1995). Consequently we investigated the remaining six orphan response regulator 
proteins, identified by the BLASTP search, as part of this work. The four orphan 
response regulators CDOI60, CD0611, CD1743, and CD2603 were chosen to be 
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investigated in the first instance, as they showed the highest percentage of 
identity/similarity to AgrA from C. acetobutylicum (excluding CD3255 and 
CDI089). 
Shortly after the study began, it was reported that CD2603, named CdtR, positively 
regulates binary toxin production in C. difficile (Carter et al., 2007). Thus, it was 
decided to omit CD2603 from the list of orphan response regulators chosen to be 
investigated in this study. 
3.2.3 Construction of mutant strains 
To investigate the role of agrB in C. difficile and in order to find a response regulator 
for the agrBD locus in C. difficile, the ClosTron system (Heap, et al., 2007; Heap, et 
al., 2010) was used to create independent insertional mutants of C. difficile 
630L\erm. The agrB, CDOI60, CD0611 and CD1743 genes were inactivated, 
yielding strains C. difficile 630L\erm agrB::CTermB, C. difficile 630L\erm 
CDOI60::CTermB, C. difficile 630L\erm CD0611::CTermB and C. difficile 630L\erm 
CDI743::CTermB, respectively. The group II intron from the ClosTron system was 
retargeted using a computer algorithm to insert into agrB, CDOI60, CD061 I and 
CD1743 in a sense orientation at position 316 bp, 246 bp, 162 bp and 390 bp, 
respectively, from the start of the ORF. 
Verification of correct ClosTron insertion was performed using two independent 
PCR screens. The gene specific and the intron specific primer revealed insertion of 
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the RAM into the target gene, and the gene specific primers flanking the insertion 
site revealed an increase in 1.9 kb in size for the mutants compared to the wildtype 
(Figure 3.1). 
CD0611 
EBS Universal 
PCRproduct 
ClosTron (1.9 kb) inserted into chromosome 
Figure 3.1 Schematic representation of the chromosomal location of the binding 
sites of the primers used screen putative CD0611 mutants. To confirm correct 
ClosTron insertion, putative mutant strains were screened by PCR using gene 
specific_FIR primer (depending on the orientation of the intron insertion) and intron 
specific primer (EBS Universal), and gene specific primers flanking the insertion 
site. When the intron is inserted into the gene of interest in a sense orientation a 
target_F primer is used along with EBS universal to screen putative mutants. 
Target_F primer binds upstream of the intron insertion site whereas EBS Universal 
binds within the intron. An amplicon will only be produced from these primers if the 
intron has inserted into the gene of interest. Putative mutants screened with gene 
specific primers flanking the insertion site produced an amplicon with a 1.9 kb 
increase in size compared to the wildtype; indicating intron insertion into the gene. 
An example of the screening procedure used is illustrated in Figure 3.2. The example 
used is for the inactivation of the CD0611 gene in C. difjicile 630 ~ e r m . . CD0611 
putative mutants were screened by PCR using the EBS Universal and 
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CD0611 124 F primers. Only if the intron has inserted into CD061l, will 
amplification from these primers occur; a 284 bp band is expected to be seen on the 
gel. As shown in Figure 3.2, the bands present in Lanes 1-5 indicate that the intron 
has inserted into CD0611. A second PCR used to screen putative mutants uses gene 
specific target_F and tagert_ R primers with the appropriate PCR controls. If the 
intron has inserted into the desired gene, the band that is expected to be seen on the 
gel will be 1.9 kb larger than the band expected from the WT genomic DNA control. 
For example for CD0611, a WT band that can be expected from the primers 
CD0611_124_F and CD0611_449_R is 358 bp. Whereas with an intron insertion in 
CD0611 the size of the amplicon produced using CD0611 124 F and 
CD0611_ 449_ R primers would be 2.2kb (358 bp + 1900 bp). 
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3Kb 
lKb 
SOObp 
12345678 
Figure 3.2 An example of PCR screening for putative C. difficile 630Aerm 
CD0611 ClosTron insertion mutants. PCR was used initially to screen for intron 
insertion using intron-specific EBS Universal primer and the gene-specific primer 
CD0611_F. Lane L =2-log ladder, I=KO genomic DNA clone 1,2 =KO genomic 
DNA clone 2, 3=KO genomic DNA clone 3, 4 =KO genomic DNA clone 4, 5=KO 
genomic DNA clone 5, 6=WT genomic DNA control, 7=pMTL007C-E2 plasmid 
DNA control, 8=water control. The bands ( ~ 3 0 0 b p ) ) shown in Lanes 1-5 indicates 
that the intron has inserted into CD0611 . 
One erythromycin-resistant clone each of C. difficile 6 3 0 ~ e r m m agrB::CTermB, C. 
difficile 6 3 0 ~ e r m m CD0160::CTermB, C. difficile 6 3 0 0 e r m m CD061l: :CTermB and C. 
difficile 6 3 0 ~ e r m m CDI743: :CTermB were picked for sequencing at the intron 
insertion site and the data confirmed the expected sequence (Table 3.1 shows intron 
insertion sites and the frequencies of the desired mutants obtained). 
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Strain and target site Frequency of desired mutant among 
clones screened 
% No. positive/no. screened 
C. difJicile 630derm agrB 80 8/10 
316s 
C. difJicile 630derm CDO 160 60 3/5 
246s 
C. difJicile 630derm CD0611 100 5/5 
162s 
C. difJicile 630derm CD 1743 100 5/5 
390s 
Table 3.1. ClosTron insertion frequencies with erythromycin selection. Introns were 
inserted after the indicated number of bases from the start of the open reading frame 
in either the sense (s) orientation. Erythromycin-resistant (630derm) clones were 
picked at random and screened by PCR to amplify the intron-exon junction. One 
clone of each desired mutant was selected, and the intron insertion site verified by 
sequencing. 
An additional experiment that can be performed to further confirm the intron 
insertion mutants is a southern blot. A southern blot will reveal that a single insertion 
has been made in the mutant strain following hybridisation of a labelled probe 
complimentary to the clostron insertion. However, due to time constraints it was not 
possible to perform southern blots on the insertion mutant strains. 
3.2.4 Phenotypic characterisation of mutant strains 
C. difJicile630derm agrB::CTermB, C. difficile 630derm CDOI60::CTermB, C. 
difJicile 630derm CD0611::CTermB and C. difJicile 630derm CD1743::CTermB 
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were phenotypically characterised. To ensure that any observed phenotypes of the C. 
difficile 6 3 0 ~ e r m m mutants are not a result from growth deficiencies, the change in 
OD600 was used to monitor growth over 24 hours in BHIS broth (Figure 3.3). The 
growth of all mutants was found to be indistinguishable from the growth of the 
parental strain, which suggests that there were no obvious growth defects following 
inactivation of agrB, CD0160, CD0611 and CD1743 respectively, in C. difficile 
6 3 0 ~ e r m . .
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Figure 3.3 The growth of C. difficile 6 3 0 ~ e r m m agrB, CDO 160, CD061 1 and CD 1743 
mutant strains in BHIS broth, as indicated by the change in OD600, during a 24 hour 
period. The symbols represent the averages of three independent experiments, and 
error bars indicate standard errors of the means. 
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3.2.4.1 Sporulation in the C. difficile 630Aerm mutant strains 
Following inactivation of agrB, CDOI60, CD0611 and CD1743 respectively, in C. 
difficile 6 3 0 ~ e r m , , these mutant strains were tested to determine their ability to form 
heat-resistant cfu after a 5-day period on BHIS agar supplemented with the bile salt 
taurocholate. Total cfulml (spores and vegetative cells) and heat-resistant cfulml 
(spores) were enumerated by serial dilution and plating onto BHIS agar 
supplemented with 0.1 % of the bile salt taurocholate before and after heat treatment 
for 30 mins at 60°C, respectively as described in Chapter 2. After 5 days there was 
no effect observed on sporulation in the C. difficile 6 3 0 ~ e r m m agrB and the three 
putative response regulators mutants (Figure 3.4). 
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Figure 3.4. Formation of heat resistant cfu of C. difficile 6 3 0 ~ e r m , , C. difficile 
6 3 0 ~ e r m m spoOA::CTermB, C. difficile 6 3 0 ~ e r m m CDOI60::CTermB, C. difficile 
6 3 0 ~ e r m m CD0611::CTermB, C. difficile 6 3 0 ~ e r m m CDI743:CTermB and C. difficile 
6 3 0 ~ e r m m agrB::CTermB agrB strains after five days. The symbols represent the 
averages of three independent experiments, and error bars indicate standard errors of 
the means. The detection limit for colony counts was 50 cfulml. 
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Therefore to test whether the onset of spore formation is delayed in these mutants 
and to determine if any effect on sporulation occurs earlier than 5 days, mutant 
strains were tested to determine their ability to form heat-resistant CFU over a 5-day 
period on BHIS agar supplemented with the bile salt taurocholate (Figure 3.5 and 
3.6). 
Inactivation of agrB, CD0160, CD0611 and CD1743 appeared to have no effect on 
sporulation in C. difficile 6 3 0 ~ e r m . . The mutant strains were able to form heat-
resistant CFU over the 5-day period at the same rate as the parental strain. This 
suggests that agrB is not required for sporulation and/or taurocholate-induced 
germination in C. difficile 6 3 0 0 e r r . . In addition it appears that neither CD0160, 
CD0611 nor CD1743, play an obvious role in either process. 
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Figure 3.5 The development of heat-resistant cfu of C. difficile 6 3 0 0 e r m m agrB 
mutant strain over five days. The symbols represent the averages of three 
independent experiments, and error bars indicate standard errors of the means. The 
detection limit for colony counts was 50 cfulml. 
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Figure 3.6 The development of heat-resistant CFU of C. difficile 6 3 0 0 e r m m CDO 160, 
CD0611 and CD1743 mutant strains over five days. The symbols represent the 
averages of three independent experiments, and error bars indicate standard errors of 
the means. The detection limit for colony counts was 50 CFU/ml. 
3.2.4.2 Toxin production in the C. difficile 630Aerm mutant strains 
To address whether the mutant strains were impaired in their ability to produce toxin 
A and B, in vitro cell cytotoxicity assays were carried out. The cell cytotoxicity 
assay uses Vero (African green monkey kidney) cells and HT29 (human colon 
carcinoma cells. Both cell lines are sensitive to both toxin A and B; in the presence 
of the toxins the cells round up and die. HT29 cells are more sensitive to toxin A and 
vero cells are more sensitive to toxin B (Torres et aI. , 1992). A four-fold dilution 
series of C. difficile culture supernatants were made and added to each cell line 
separately (i .e. HT29 and Vero cells). After an incubation period of 24 hours, 
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cytotoxicity was determined as objectively as possible by finding the end point titre 
of each dilution series, rather than a using a subjective cell scoring system. End-point 
titre is defined as the first dilution in the series in which the morphology of the HT29 
or Vero cells is the same as the negative controls. The negative controls for the 
cytotoxicity assays were cells that had been incubated with un inoculated C. difficile 
culture medium (Figure 3.7). 
Inactivation of agrB, CDOI60, CD0611 and CDl743 appeared to have no effect on 
toxin production in C. difficile 6 3 0 ~ e r m . . The mutant strains exhibited similar levels 
of toxicity towards the vero cells in comparison to the parental strain. A similar 
cytotoxic effect was also seen on the HT29 cells by the C. difficile 6 3 0 ~ e r m m mutant 
strains (Figure 3.8a, b and Figure 3.9a, b). This suggests that both the toxins were 
present in abundance in the supernatant that was collected from the strains prior to 
being added to the cell monolayer indicating that there toxin gene expression had not 
been impaired. 
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Figure 3.7 The cytotoxic effect of C. difficile 630b.erm on Vero cells. Culture supernatant of C. difficile 630b.erm was added to a flat monolayer ofVero cells in fourfold 
dilution series. After a 24 hour incubation, toxin end point titres were detennined. A. Vero cells inoculated with C. difficile 630b.erm supernatant at dilution 1:4 B. Vero cells 
inoculated with C. difficile 630b.erm supernatant at dilution 1:4096 C. Vero cells inoculated with C. difficile 630b.erm supernatant at dilution 1:4194304 D. Vero cells 
incubated with uninoculated culture medium E. Untreated Vero cells. 
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Figure 3.8 In vitro cytotoxicity assays, Supernatants of the parental strain and the 
agrB mutant strain were used in cell culture assays to measure cytotoxicity, Vero 
cells (a) and HT29 cells (b) were cultured to a flat monolayer before adding C. 
difficile supernatants in a fourfold dilution series, After a 24 hour incubation, toxin 
end point titres were determined 
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CD1743 mutant strains. See figure legend above for details. 
97 
3.2 Discussion 
Progress in the genetic manipulation of many clostridia, and particularly C. difficile, 
has been severely delayed by a historic lack of methods for the directed mutagenesis 
of targeted genes. However, the recent development of the ClosTron system has 
now opened the way for studying C. difficile using a reverse genetics approach 
(Heap, et al., 2007; Heap, et al., 2010). Consequently, it is imperative that we gain a 
greater understanding how C. difficile, such a prevalent pathogen in worldwide 
hospitals, regulates the production of its virulence factors such as the expression of 
Toxin A and Toxin B and sporulation. The work described in this chapter set out to 
investigate the role of agrB in C. difficile 630 and to find a response regulator for the 
agrBD locus in C. difficile 630. 
Unfortunately the precise mechanism by which toxin production and sporulation are 
regulated in C. difficile 630 remains unclear. The work presented above suggests that 
the C. difficile 6 3 0 ~ e r m m agrB mutant and the three C. difficile 630 ~ e r m m putative 
agrA mutants (CDOI60, CD0611 and CD1743) play no obvious role in the 
production of toxin A and toxin B or sporulation. 
The mutants were tested in their ability to form heat-resistant cfu after a 5-day period 
on BHIS agar supplemented with the bile salt taurocholate. After 5 days there was no 
effect observed on sporulation in the C. difficile 6 3 0 ~ e r m m agrB and the three 
putative response regulators mutants. However, sporulation in agr mutants made in 
both C. acetobutylicum and C. botulinum is substantially reduced (Minton lab, 
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unpublished data; Cooks ley et al., 2010). Subsequently we decided to investigate 
whether the onset of spore fonnation is delayed in these mutants and to detennine if 
any effect on sporulation occurs earlier than 5 days. The mutant strains were tested 
to detennine their ability to fonn heat-resistant CPU over a 5-day period on BHIS 
agar supplemented with the bile salt taurocholate. Our data indicates that the mutant 
strains were able to fonn heat-resistant CPU over the 5-day period at the same rate as 
the parental strain. This suggests that agrB is not required for sporulation and/or 
taurocholate-induced gennination in C. difficile 6 3 0 ~ e r m . . In addition it appears that 
neither CDOI60, CD0611 nor CD1743, play an obvious role in either process. 
To address whether the mutant strains were impaired in their ability to produce toxin 
A and B, in vitro cell cytotoxicity assays were carried out using Vero cells and HT29 
cells. The mutant strains had no effect on toxin production in C. difficile 6 3 0 ~ e r m m as 
there was no reduction in toxicity towards both the vero and HT29 cells in 
comparison to the parental strain. This suggests that both the toxins were present in 
the supernatant that was collected from the strains prior to inoculation onto the cell 
monolayer, indicating that toxin gene expression had not been impaired. It is unclear 
using the cell cytotoxicity assays whether the amount of either one of the toxins is 
more/less prevalent in the mutant strains as both cell lines are sensitive to both toxin 
A and B. Even though it has been reported that HT29 cells are more sensitive to 
toxin A and vero cells are more sensitive to toxin B (Torres et aI., 1992) this 
sensitivity was not observed during the cell assays with these mutant strains as a 
similar degree of toxicity was shown by the mutants strains towards both the vero 
and HT29 cells. To confinn whether expression of either toxin was impaired in any 
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way by inactivation of agrB and the response regulator mutants, a toxin 
neutralisation assay could be performed. The culture supernatant of the mutant 
strains would be incubated with toxin A or toxin B specific antibodies before being 
inoculated on the vero or HT29 cells. The culture supernatants are diluted so that 
only toxin A is detected using the HT29 cells and only toxin B is detected using the 
vero cells. This assay would allow you to distinguish whether expression of toxin A 
and toxin B had been impaired by inactivation of agrB and the response regulators. 
If a positive result was observed using the neutralisation assay, quantitative reverse 
transcriptase PCR analysis could be used to confirm whether toxin expression had 
been affected in any of the mutant strains. 
Further checks on the stability of the insertion mutants could be performed to check 
that the ClosTron is still located in the same place after growth curves, sporulation 
assays and toxin assays. This could be done by using the PCR screening method that 
was initially used to confirm the location of the ClosTron as well as performing a 
Southern Blot to confirm there is still a single ClosTron insertion in the mutant 
strains after the functional assays. 
Even though sporulation in agr mutants made in both C. acetobutylicum and C. 
botulinum and neurotoxin production in agr mutant strains of C. botulinum is 
substantially reduced (Minton lab, unpublished data; Cooksley et al., 2010), our data 
shows that C. difficile 630 does not regulate sporulation and toxin production in a 
similar manner to other members of the clostridia species. It remains unclear what 
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role the agr system has in C. difficile 630 or even if agr has a functional role in 
regulation of virulence in C. difficile 630. With no apparent two-component system 
(to detect the auto inducing peptide and induce gene expression) present within the 
vicinity of the agrBD locus in genome sequence of C. difficile 630, it may be 
possible that agr does not have a functional role in regulation in C. difficile 630. This 
could be determined by investigating whether agrD produces an autoinducing 
peptide (AlP) by trying to isolate it from culture supernatant using mass 
spectrometry. 
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Figure 3.10 AgrD protein alignments. A Alignment of putative clostridial AgrD proteins with those of the four S. aureus AlP groups. Bold 
residues indicate the sequence of the mature AIP. B Alignment of putative AgrD proteins from five clostridial species. C. spor, C. sporogenes; 
C. bot, C. botulinum; C. perf, C. perfringens; C. diff, C. difficile; S. a, S. aureus; C. aceto, C. acetobutylicum. Residues coloured red are 
completely conserved. Residues coloured blue are partially conserved. Bold residues indicate the possible AIP sequence, with purple residues 
forming the thiolactone ring and green residues forming the tail. The length of the tail may, however, be shorter than indicated. 
The amino acid sequences of the AlP's in S. aureus vary greatly, however a central 
cysteine is conserved in all of them. The cysteine is important for the formation of a 
thiolactone ring with the C-terminal amino acid (Muir, 2003). The amino acid 
sequence of C. difficile AgrD is completely different from the amino acid sequence 
of other AlP's including the AgrD amino acid sequences of C. acetobutylicum, C. 
botulinum, C. sporogenes and C. perjringens, however the same central cysteine is 
conserved (Figure 3.10). If an AlP is produced by C. difficile it would be of great 
interest to determine whether the AlP is functional, although it would be beneficial if 
there was a phenotype that could be assayed to test this. 
The work presented in this study shows that agrB plays no obvious role in the 
regulation of virulence factors in C. difficile 630. The data obtained from the three 
orphan response regulators, identified from the BLASTP search, suggest that these 
response regulators may not be the response regulator of the agrBD locus in C. 
difficile 630. 
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Chapter 4 
Identification and analysis of a putative 
quorum sensing system in Clostridium difficile 
R20291 
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4.1 Introduction 
4.1.1 Emergence of 'hypervirulent' strains of C. difficile 
The recent increase in the number CDAD cases has been linked to the rapid 
emergence of C. difficile strains belonging to restriction endonuclease type BI, North 
American pulsed-field type 1 (NAP1) and PCR-ribotype 027 (BVNAPlI027) (Pepin, 
et aI., 2004; Kuijper, et aI., 2007). In the UK, these highly virulent and epidemic 
strains of C. difficile were rarely isolated from patients suffering from CDAD prior 
to 2005, but have recently become highly represented among such clinical isolates. 
PCR ribotype 027 strains cause> 33% of the 50,000 cases of CDAD reported in the 
UK (Brazier et al., 2008). The BVNAPlI027 type is now the most commonly 
isolated C. difficile type in England (Figure 4.1). Across mainland Europe, cases of 
CDAD associated with the BVNAPlI027 type have been reported in 16 countries 
(Kuijper, et al., 2008) In North America, these strains have largely been associated 
with the over-use of quinolone antibiotics and are responsible for an increase in the 
incidence of nosocomial CDAD, more severe disease, higher relapse rates, increased 
mortality, and greater resistance to fluoroquinolone antibiotics (Kuijper, et aI., 
2006). Furthermore, the BVNAPlI027 type has recently been linked with the 
emergence of community-associated CDAD, no longer limiting C. difficile to the 
healthcare environment (Rupnik, et al., 2009). 
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Figure 4.1 Distribution of C. difficile PCR ribotypes in England in 2007-8, adapted 
from Brazier et al. (2008). The data represent the national distribution of PCR 
ribotypes identified from a study of 677 individual isolates. The incidence of cases 
due to type 027 strains increased by 15.4% compared to a study in 2005, and the 
percentage of type 001 and type 106 cases fell by 17.3% and 6%, respectively 
(Brazier, et aI., 2008). 
There are a number of studies showing that patients infected with the PCR-ribotype 
027 strains have more severe diarrhoea, a higher mortality rate and a higher level of 
reoccurrence (Loo et al., 2008; Goorhuis et al., 2007; Redelings et al. , 2007; Pepin 
et al., 2004). This has been exemplified by the PCR ribotype strain R2029l which 
was responsible for the outbreak at the Stoke Mandeville hospital in the UK in 
200412005 (Stabler et al., 2009). Unsurprisingly, there is a widespread interest in the 
field to understand why strains such as those of the BIINAPI /027 type can cause a 
more severe disease than other types, and why incidence and relapse rates appear 
higher where the BIINAPlI027 type is isolated. Studies have shown that a number 
ofBIINAPlI027 strains produce higher levels of toxin in the laboratory, although the 
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mechanisms for this increased toxin production remain unclear (Wamy, et aI., 2005). 
In addition, it has been suggested that strains of the BIINAPlI027 type are more 
prolific in terms of sporulation than non-outbreak strains (Wilcox and Fawley, 2000; 
Fawley, et al., 2007; Akerlund, et al., 2008). However, to-date it is still not clear 
exactly what causes the increased disease incidence and severity associated with 
BIINAPlI027 strains of C. difficile. 
4.1.2 C. difficile rihotype 027 specific genes 
Studies to understand the recent emergence of the hypervirulent strain of C. difficile 
is gathering momentum. Stabler et al. (2009) compared a 'historic' non-epidemic 
027 C. difficile (CD196) strain, a recent epidemic and hypervirulent 027 (R20291) 
strain and a PCR-ribotype 012 strain (630). Their findings showed that even though 
the genomes are highly conserved, the 027 genomes have 234 additional genes 
compared to 630. They found that the epidemic 027 strain has five unique genetic 
regions, which are absent from both the non-epidemic 027 and strain 630. These 
unique regions include a two component regulatory system and transcriptional 
regulators. 
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4.1.3 C. difficile ribotype 027 specific regulatory genes 
A large proportion of the 027 -specific genes are comprised of regulatory genes. The 
work of Stabler et ai. (2009) described that in 027 strains there are eight two-
component regulators and fifteen other transcriptional regulators. One of the most 
interesting findings in this study is that in PCR ribotype 027 strains there is an 
additional copy of the complete agr locus, termed agr2. The additional agr2 locus 
contains homologues of agrA, agrC, agrD and agrB. The agrl locus found in C. 
difficile 630 is also present in the ribotype 027 strains. Analysis of the R20291 
genome sequence showed that downstream of the agr2locus three more 027-specific 
CDS; encoding two putative membrane proteins and an ABC transporter ATP-
binding protein. 
The occurrence of the agr2 locus in different C. difficile strains was investigated as 
part of a comparative study of 94 clinical strains, the most common PCR-ribotypes 
isolated in mainland Europe and the UK, by array comparative genomic 
hybridisation (Marsden et ai., 2010). The study revealed that the agr2locus is found 
in the genomes of 82 of the 94 (86%) strains tested, including two of four non-
toxinogenic strains tested. 
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4.1.4 Aims of this study 
There are a number of gene differences between ribotype 027 strains, in particular 
the presence of an additional complete agr2 locus. These genes difference may 
contribute to understanding why modem PCR ribotype 027 strains are associated 
with a higher case-fatality ratio and persistence. One of the first characteristic of 
BIINAPlI027 strains to be associated with hypervirulence was the production of 
toxins, the major virulence factor of C. difjicile. As described previously, a number 
of BIINAPlI027 strains have been shown to produce higher levels of toxin in vitro 
(Wamy, et aI., 2005), although the molecular basis of this observation remains 
unclear. As the PCR ribotype 027 strains carry an extra copy of the complete agr 
locus, we reasoned that toxin production in these strains may be under the regulatory 
control of the agr2 locus. The study presented in this chapter sets out to investigate 
the role of the second agr locus in regulation of virulence factors. 
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4.2 Results 
4.2.1 Construction of mutant strains 
To investigate the role of agr in C. difficile Rl0291, the ClosTron system (Heap, et 
al., 2007; Heap, et at., 2010) was used to create independent insertional mutants of 
C. difjicile Rl0291 in which the agrBl, agrB2 and agrA genes were inactivated, 
yielding strains C. difjicile Rl0291 agrBl::CTermB, C. difjicile R2029 I 
agrB2::CTermB and C. difjicile R20291 agrA::CTermB, respectively. 
The group II intron from the ClosTron system was retargeted using a computer 
algorithm to insert into agrBl and agrB2 in an antisense orientation at position 362 
bp and 313 bp, respectively (from the start of the ORF), and in the sense orientation 
for agrA at position 306 bp. 
As described in previous chapters, to confirm correct ClosTron insertion, putative 
mutant strains were analysed by PCR, and one lincomycin-resistant clone each of C. 
difjicile R20291 agrBl::CTermB, C. difjicile R20291 agrB2::CTermB and C. 
difjicile R20291 agrA::CTermB were picked for sequencing at the intron insertion 
site and the data confirmed the expected sequence. 
4.2.2 Phenotypic characterisation of mutant strains 
C. difjicile R20291 agrBl::CTermB, C. difjicile Rl0291 agrB2::CTermB and C. 
difjicile R20291 agrA::CTermB were phenotypically characterised. To ensure that 
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any observed phenotypes of the C. difficile R20291 agr mutants are not a result from 
growth deficiencies, all C. difficile R20291 agr mutant strains were first cultivated in 
BHIS broth for 24 h, and growth was monitored by measuring the change in OD600 
(Figure 4.2). All strains showed highly similar growth characteristics, which 
suggests that there were no obvious growth defects following inactivation of agrB 1, 
agrB2 and agrA in C. difficile R20291. This allows for the exclusion of growth 
differences when interpreting the subsequent experiments in this chapter. 
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Figure 4.2 Growth of C. difficile R20291 agr mutants in BHIS broth over five days. 
Strains were cultivated as described in Chapter Two, and the OD600 measured. The 
symbols represent the averages of three independent experiments, and the error bars 
represent standard errors of the means. 
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4.2.2.1 Sporulation in the C. difficile R20291 agr mutant strains 
In order to understand if agr is involved in spore formation in C. difficile R20291 , 
the development of heat-resistant CFU was measured over 5 days. At 24 h time 
intervals, samples were heated at 60 °C for 25 min to kill vegetative cells but not 
spores, and plated onto BHIS agar supplemented with the bile salt taurocholate to 
recover viable C. difjicile spores. The observed colony formation appeared to show 
a degree of variation in the sporulation rates between C. difjicile R20291 agr mutant 
strains (Figure 4.3) 
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Figure 4.3 Development of heat-resistant CFU of C. difjicile R20291 agr mutants 
over 5 days on BHIS agar supplemented with 0.1 % taurocholate. C. difjicile strains 
were cultivated as described in Chapter Two. The symbols indicate the averages of 
three independent experiments, and the error bars indicate standard errors of the 
means. The detection limit for the assay was 50 CFU/ml. 
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There are no obvious differences in the number of heat-resistant cfu or in the rate at 
which the heat-resistant cfu are formed over 5 days in the C. difficile R20291 agrA 
mutant strain in comparison to the parental strain. Surprisingly, the initiation of 
heat-resistant cfu formation occurs earlier (at 24 hours) in the C. difficile R20291 
agrB2 mutant compared to the parental strain and the C. difficile R20291 agrA 
mutant. On the other hand, heat-resistant cfu are formed later (at 72 hours) in the C. 
difficile R20291 agrBI mutant compared to the parental strain. It would be expected 
that agr mutants of the agr2 locus (agrB2 mutant and agrA mutant) would behave 
the same in terms of when they sporulate, however these results show that is not the 
case here. 
Interestingly, once sporulation was initiated in the agrBI mutant after 72 hours, there 
was a significant lower level of heat-resistant cfu formed by this mutant in 
comparison to the other strains (p <0.05). After 120 hours, the level of heat resistant 
cfu was also significantly lower in the agrBI mutant when compared to the other 
stains. In contrast, the agrB2 mutant formed significantly more heat-resistant cfu, 
earlier than the other stains and significantly more heat-resistant cfu were observed 
after 120 hours in the agrB2 mutant when compared to the other strains (p <0.05). 
This suggests that in a case where a strain initiates sporulation particularly early, the 
strain also forms a higher total of spores than a strain which initiates sporulation at a 
later stage. 
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4.2.2.2 Toxin production in the C. difficile R20291 agr mutant strains 
In order to understand if agr is involved in toxin A and B production in C. difficile 
R20291, in vitro cell cytotoxicity assays were carried out. Cells were incubated for 
24 hours with a fourfold dilution series of C. difficile culture supernatants. 
Cytotoxicity of the C. difficile strains towards the vero cells and HT29 were to a 
similar degree; there was no obvious difference in cytotoxicity between the cell 
lines. The agrBl mutant showed a similar degree in toxicity towards both the vero 
cells and HT29 as the parental strain. Interestingly, the agrB2 and agrA mutants 
showed significantly reduced toxicity towards the vero cells and HT29 cells (p 
<0.05) (Figure 4.4). This indicates that the agr210cus in C. difficile R2029 1 may be 
indirectly involved in toxin A and toxin B production. 
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Figure 4.4 In vitro cytotoxicity assays. Supernatants of the parental strain and the 
three agr mutant strains were used in cell culture assays to measure cytotoxicity. 
Vero cells (a) and HT29 cells (b) were cultured to a flat monolayer before adding C. 
difficile supernatants in a fourfold dilution series. After a 24 hour incubation, toxin 
end point titres were determined. 
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4.2.3 Complementation of the agr mutants with the parental agr loci 
In order to show that the observed phenotypes of the agr mutants were a specific 
consequence of inactivation of agrBI, agrB2 and agrA respectively, 
complementation studies were performed. Plasmid pMTL84151 :: agr 2 was 
constructed, which contains 2,915 bp of the parental agr2 locus coding region, the 
400 bp region immediately upstream of the open reading frame presumed to contain 
its promoter and 269 bp region immediately downstream of the agr2 locus. 
Strains C. difficile R20291 agrB2::CTermB (pMTL84151::agr2) and C. difjicile 
R20291 agrA::CTermB (pMTL84151::agr2) were created by introducing this 
plasmid into the agrB2 and agrA mutants of C. difjicile R2029 I , respectively. 
Empty vector control strains C. difficile R20291 agrBl::CTermB (pMTL84151) and 
C. difficile R20291 agrA::CTermB (pMTL84151) were also created through 
introduction of pMTL84151 into the respective agr mutant strains. 
Plasmid pMTL8415I : :agrBD 1 was constructed, which contains 806 bp of the 
agrBD structural genes and 452 bp 5' non-coding region was cloned into the 
modular plasmid pMTL84151 (Heap, et al., 2009) to generate plasmid 
pMTL84151::agrBDI. The C. difficile R20291 agrBl::CTermB 
(pMTL84151 : :agrBD 1) strain was created by introducing the plasmid into the 
mutant strain by conjugation. 
Successful plasmid transfer was confirmed by recovery of the plasmid, followed by 
peR and/or restriction analysis. In order to control for the thiamphenicol selection 
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needed to maintain the plasm ids in culture, strains C. difficile 6 3 0 ~ e r m m
(pMTL84151) and C. difficile R20291 (pMTL84151) were used in the assays. The 
development of heat-resistant CFU was then measured in the same way as previously 
described, and the data were compared to data obtained previously. 
4.2.3.1 Sporulation in the complemented C. difficile R20291 agr mutant 
strains 
The levels of heat-resistant cfu were fully restored in the agrBl mutant strains of C. 
difficile R20291 carrying pMTL84151: :agrBD 1 to the levels of the parental strains 
carrying the control vector pMTL84151 (Figure 4.5). Sporulation in the agrBl 
mutant strain and the agrBl mutant strain carrying the empty vector occurred after 
72 hours. Whereas the sporulation profile of the agrBl mutant carrying 
pMTL84151: :agrBD 1 was the same as the C. difficile R20291 parental strain in 
which sporulation is initiated after 48 hours. The parental strain harbouring the 
empty vector performed like the plasmid free parental strain, sporulation was 
initiated after 48 hours in both strains. However, in the case of R2029 I there was a 
slight difference between the level of heat-resistant cfu obtained for the strain with 
the control plasmid and the level obtained for the plasmid-free parental strain. This 
difference is presumably as a result of growth under thiamphenicol selection 
conditions, as the antibiotic selection may affect the sporulation frequency of 
R20291. The agrB 1 mutant controls containing the empty vector performed like the 
original mutant, sporulation was initiated after 72 hours. Thus it was possible to 
complement the defect in the delayed onset of the formation of heat-resistant cfu 
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observed in the C. difficile agrBl mutant, indicating that the observed phenotype 
was due solely to inactivation of agrBl. 
There was a slight difference between the level of heat-resistant cfu obtained for the 
agrB2 (pMTL84151::agr2) strain, the strain with the control plasmid and the level 
obtained for the plasmid-free parental strain. This difference is presumably as a 
result of growth under thiamphenicol selection conditions which may affect the 
sporulation frequency of R2029 1. The agrBl mutant controls containing the empty 
vector performed like the original mutant, sporulation was initiated after 48 hours. 
As expected, there is no difference in the onset of sporulation in the C. difficile 
R2029 I agrA complemented strains compared to the agrA mutant strain (Figure 
4.6b). The sporulation profiles of these strains are similar with sporulation being 
initiated at 48 hours. 
The sporulation profile of the agrB2 mutant strain of C. difficile carrymg 
pMTL84 I 5 I : :agr 2 was not the same as the sporulation profile of the parental strain. 
Sporulation in the agrB2 mutant is initiated after 24 hours, whereas sporulation in 
agrB2 (pMTL84151::agr2) strain was also initiated at 24 hours unlike the parental 
strain which sporulates after 48 hours (Figure 4.6a). The results of the 
complementation study suggest that agr2 may not be expressed from the plasmid 
pMTL84151::agr2. This could be tested by modifying the plasmid with a 
heterologous promoter as it appears that the 5' non-coding region did not result in 
expression of the agr2 locus. On the other hand, expression of the agr2 locus may 
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not be the cause of the failure to complement the mutant strain using this plasmid 
pMTL84151 : :agr 2 and instead this could be due to the ClosTron insertion in these 
mutant strains having a polar effect on gene expression. There also may be 
transcriptional terminators present in the DNA sequence within the region of the agr 
locus. It would be useful to search the DNA sequence of the agr region for such 
transcriptional terminators as this may explain the why it was not possible to 
complement the mutant strains using plasmid pMTL8415l: :agr 2. Unfortunately due 
to time constraints it was not possible to perform cytotoxicity assays with the 
complemented C. difficile agr mutant strains in this study. 
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Figure 4.5 Development of heat-resistant CFU of C. difjicile R20291 agrBl complemented mutants 
over 5 days on BHIS agar supplemented with 0.1 % taurocholate. C. difjicile strains were cultivated as 
described in Chapter 2. The symbols indicate the averages of 3 independent experiments, and the error 
bars indicate standard errors of the means. The detection limit for the assay was 50 CFU/ml. 
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Figure 4.6 Development of heat-resistant CFU of a) C. difficile R20291 agrB2 complemented 
mutants and b) C. difficile R20291 agrA complemented mutants over 5 days on BHIS agar 
supplemented with 0.1 % taurocholate. C. difficile strains were cultivated as described in Chapter 
Two. The symbols indicate the averages of three independent experiments, and the error bars 
indicate standard errors of the means. The detection limit for the assay was 50 CFUlml. 
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4.3 Discussion 
There are a number of gene differences between peR ribotype 027 strains, III 
particular the presence of an additional complete agr2 locus. These genes differences 
may contribute to understanding why modern 027 strains are associated with a 
higher case-fatality ratio and persistence. One of the first characteristic of 
BIINAPlI027 strains to be associated with hypervirulence was the production of 
toxins, the major virulence factor of C. difficile. As described previously, a number 
of BIINAPlI027 strains have been shown to produce higher levels of toxin in vitro 
(Warny, et al., 2005), although the molecular basis of this observation remains 
unclear. As the ribotype 027 strains carry an extra copy of the complete agr locus, it 
was hypothesised that toxin production in these strains are under the regulatory 
control by the agr2 locus. In this study, the role of the second agr locus was 
analysed to determine whether the agr homologues are involved in the regulation of 
toxin production and sporulation. 
The data presented above shows that there is some variation in the sporulation 
profiles of the C. difficile R20291 agr mutants. We observed that there are no 
obvious differences in the rate at which the heat-resistant cfu are formed over 5 days 
in the C. difficile R20291 agrA mutant strain in comparison to the parental strain. In 
contrast to this, the onset of sporulation in the C. difficile R20291 agrBl mutant is 
delayed, heat-resistant cfu are formed after 72 hours, in comparison to the parental 
strain. The delayed onset of sporulation was fully restored in C. difficile R20291 
agrBl mutant strains carrying pMTL84151::agrBDl and the complemented agrBl 
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mutant behaved in a similar manner to the C. difficile R20291 parental strain (Figure 
4.5) indicating that the observed phenotype was due solely to inactivation of agrBI. 
In the C. difficile R20291 agrB2 mutant heat-resistant cfu formation is initiated after 
24 hours, whereas the parental strain sporulates after 48 hours. Unfortunately it was 
not possible to complement the agrB2 mutant. Sporulation in the agrB2 mutant is 
initiated after 24 hours, whereas sporulation in agrB2 (pMTL84151 : :agr 2) strain was 
also initiated at 24 hours unlike the parental strain which sporulates after 48 hours 
(Figure 4.6a). The results of the complementation study suggest that agr2 may not be 
expressed from the plasmid pMTL84151::agr2. To address this the plasmid could be 
modified with a heterologous promoter as 5' non-coding region did not result in 
expression of the agr2 locus. The stability of the plasmid in the complemented 
strains should be tested to ensure that the plasmid has not been lost during the 
sporulation assay. In addition to this it would also be useful to check that plasmid 
pMTL84151 : :agr 2 has not recombined with homologous sequences in the genome. 
Interestingly, the agrBI mutant of C. difficile R20291 behaves differently in terms of 
sporulation when compared to the agrB mutant of C. difficile 6 3 0 ~ e r m . . It is not clear 
why it would be beneficial for R20291 , a strain which has two agr loci, to regulate 
the onset of sporulation in this way. Another species of clostridia that carries two 
copies of the agr loci is C. botulinum. The work of Cooksley and co-workers (2010) 
demonstrated that inactivation of agrl and agr2, respectively, affected sporulation in 
both of these mutant strains. Even though the agrl mutant showed a greater 
reduction in sporulation than the agr2 mutant, it is apparent that the two agr loci in 
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C. botulinum are working in tandem. Unfortunately this was not observed in C. 
difficile R20291 thus it is difficult to draw any definite conclusions from these 
findings but it is clear the sporulation in C. difficile is a very complex process. 
The C. difficile R20291 agrBI mutant showed a similar degree in toxicity towards 
both the vero cells and HT29 cells as the parental strain. However, both agr2 
mutants of C. difficile R20291 displayed a reduction in cytotoxicity in vitro (Figure 
4.4). In light of these findings, it can be concluded that the agr2 locus may playa 
secondary role in the regulation of toxin production in C. difficile. The exact 
mechanisms of how this is elucidated remains unclear however it could be possible 
that the two additional ALP's produced in this strain act as a molecular switch and 
increase toxin production. In contradiction to our observations, preliminary 
microarray studies performed with the C. difficile R20291 agrA mutant has revealed 
that in the agrA mutant strain expression of the PaLoc (pathogenecity locus which 
encodes the toxin A and B genes) is upregulated during late exponential/stationary 
growth (R. Stabler, personal communication). The research into regulatory pathways 
of C. difficile is still relatively new. However, with the findings of this study it may 
help us further our understanding of how the so called hypervirulent strain causes 
disease. 
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Chapter 5 
Further analysis of the agr2locus 
124 
5.1 Introduction 
C. difficile is one of the most intensively typed pathogens, with a wide range of 
systems applied in order to understand its epidemiology. The emergence of C. 
difficile strains belonging to restriction endonuclease type BI, North American 
pulsed-field type 1 (NAPl) and PCR-ribotype 027 (BIINAPlI027) has contributed to 
the problem of increased CDAD incidence (Pepin, et al., 2004; Kuijper, et al., 2007). 
These so-called 'hypervirulent' types of C. difficile were in the past isolated 
infrequently from patients suffering from CDAD, but have recently become highly 
represented among such clinical isolates. 
Outbreaks of CDAD due to the BlINAPlI027 C. difficile strains continue to be 
reported and these types are now the most clinically relevant type in the United 
Kingdom (Brazier et al., 2008). In the last decade there has been a 35-fold increase 
in reported cases of CDAD in the United Kingdom (Stabler et al., 2009). The 
BlINAPlI027 strains are associated with more severe disease. In addition, patients 
infected with these strains often experience more recurrent episodes and higher 
mortality (Loo et al., 2005). Consequently, the studies of the mechanisms behind the 
pathogenesis of the BlINAPlI027 strains are now at the forefront of C. difficile 
research worldwide. 
There are a number of genes specific to the PCR ribotype 027 strains, a large 
proportion of which comprise of regulatory genes. Interestingly, PCR ribotype 027 
strains carry an additional copy of the complete agr locus which is not found in the 
C. difficile 630 genome. 
125 
5.1.1 Aim of this study 
The work described in Chapter 4 showed that the second agr locus (agr2) may playa 
role in toxin A and toxin B production in C. difficile R20291. In light of these 
findings, the work described in this study sets out to further characterise the agr2 
locus by investigating transcriptional linkage of the agr genes. In addition to this, the 
study also aims to analyse the effect on toxin A and toxin B production in the C. 
difficile 630derm strain harbouring a plasmid containing the agr210cus. 
5.2 Results 
5.2.1 Reverse Transcriptase PCR (RT -PCR) analysis to investigate 
linkage of agr gene expression in C. difficile 
RT-PCR was used to determine whether the genes within and flanking the two agr 
regions of C. difficile R20291 and the agr region of C. difficile 630 are 
transcriptional linked. RNA was extracted, as described in Chapter 2, during early 
and late exponential growth, when OD600 readings were 0.4 and l.0 (Figure 5.1). The 
amount of total RNA temple used was consistent for each RT-PCR reaction, 11lg 
RNA template per reaction. Nine primer sets for C. difficile R20291 and nine primer 
sets for C. difficile 630 were designed; each set spanning two genes within the agr 
regions (Figure 5.2 1 and 2). Primer sequences can be found in Chapter 2. Control 
reactions were carried out without reverse transcriptase to ensure amplification was 
not due to genomic DNA contamination. In addition, a positive control was also 
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carried out using a DNA template to ensure that the cycling conditions used were 
sufficient. 
With the exception of the results obtained with the primers spanning pts! and 
CD2641, the results in Figure 5.2(a) suggests that all of the genes in the agr region I 
are transcriptionally linked. It appears that transcription occurs during both early and 
late exponential growth and there is not an obvious difference in expression levels 
between the two time points. The negative result obtained with the primers spanning 
pts! and CD2641 are somewhat surprising as there is no amplification in with the 
positive control either. Prior to being used in the RT-PCR reactions, the primers that 
were designed to amplify ptsVCD2753 were tested on a genomic DNA template 
using a Phusion Taq polymerase (Promega) to ensure the primers were annealing 
correctly and there was no non-specific amplification. The results of the test showed 
that the primers annealed and amplified as expected, data not shown. The lack of 
amplification in the positive control during the RT-PCR could potentially be due to 
the HotStar taq polymerase (Qiagen), which is used for the RT -PCR, not being able 
to produce an amplicon greater than lKb. 
The RT-PCR results shown in Figure 5.2(b) also suggest that in agr region 2, all the 
genes within the region are co-expressed (gene pairs 
CDR20291_3192/CDR20291_3191, CDR20291_31911CDR20291_3190, 
CDR20291_3190/agrA, agrA/agrC, agrC/agrD2, agrD2/agrB2. 
agrB2/CDR20291_3186, CDR20291 3 I 86/CDR20291 3185 
- -
and 
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CDR20291 _3185/CDR20291 _3184). Once agam, all gene pam which are co-
expressed show expression throughout early and late exponential growth and there is 
no obvious difference in the levels of expression at the two time points analysed. 
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Figure 5.1 Growth of C. difficile R20291 in TY broth for RNA extractions. The 
arrows show when samples were taken for RNA extraction. Strains were cultivated 
as described in Chapter 2, and the OD600 measured. 
128 
1 
(a) 
agr region 1 (C dtlJicile R202911630) 
A 
ptsl * ~ ~
2022bp 
A 
B 
CD2641 * ~ ~
~ ~
C;; 
• ••• 
779bp 322bp 
B C 
c 
452bp 
o 
CD2749 ~ ~ CD2748 ~ ~
D 
563bp 
E 
551bp 
F 
E 
ubiB ~ ~
Figure 5.2 Reverse transcriptase peR to show linkage of agr gene expression in C. difficile strains R20291 and 630. For fulllengend see next page. 
F 
* pIS] and CD2641 are annotated as CD2753 and CD2751 respectively in the C. difficile 630 genome sequence. Primers to amflify the integenic region between 
the two genes were the same as those used with C. difficle R20291 RNNDNA template. 
2 
G 
agr region 2 (C d{fflcile R20291) 
CDR20291_3192 
H 
432bp 
G 
CDR20291_3191 
513bp 
H 
~ ~ E E ~ ~~ ~ ~ ~ .,,,,, 
~ ~
CDR20291_3190 
• ••• 
545bp 
J 
343bp 
J 
K 
------- -------381bp 356bp 
K L 
L 
352bp 
M 
CDR20291_3186 
337bp 
N 
M 
CDR20291_3185 CDR20291_3184 
-------327bp 
o 
N 
Figure 5.2 Reverse transcriptase peR to show linkage of agr gene expression in C. difficile. agr region 1 in C. difficile R20291 and 630 and agr region 2 in C. difficile 
R20291 are shown by 1 and 2. The bars spanning the intergenic regions between genes represent the fragments (A-O) amplified by RT-PCR. The RNA template used in the RT-
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template (DNA) in place of the RNA template to ensure the cycling conditions were sufficient. 
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5.2.2 Introducing the agr2 locus into C. difficile 630Aerm and its effect 
on toxin production. 
Hypervirulent PCR ribotype 027 strains have been characterised to produce more 
toxin than other C. difficile strains. It can speculated that the agr2 locus plays a 
regulatory role in the increased toxin phenotype displayed the ribotype 027 strains. 
Therefore to test this theory, plasmid pMTL84151::agr2 was introduced into C. 
difficile 630 t1erm creating C. difficile 630t1erm (pMTL84151: :agr2). Successful 
plasmid transfer was confirmed by recovery of the plasmid, followed by PCR and/or 
restriction analysis. 
In order to determine if the levels of toxin A and B production in the C. difficile 
630t1erm (pMTL84151::agr2) resemble those seen in C. difficile R20291, in vitro 
cell cytotoxicity assays were carried out. Cells were incubated for 24 hours with a 
fourfold dilution series of C. difficile culture supernatants as described previously. 
Interestingly, the level of cytotoxicity towards vero cells exhibited by C. difficile 
630t1erm (pMTL84151: :agr2) were to the same degree as those seen with C. difficile 
R20291 (Figure 5.3). This increase in cytotoxicity by C. difficile 630t1erm 
(pMTL84151::agr2) was also seen in the HT29 cells. The results were surprising as 
the agr2 plasmid (pMTL84151::agr2) was unable to complement the C. difficile 
R20291 agrB2 mutant. However, when the plasmid was introduced into C. difficile 
630t1erm it appears that expression of the agr2 locus from the plasmid is sufficient 
and when a high copy number of the agr2 locus is present in C. difficile 630t1erm, it 
increases its toxicity in vitro. 
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Figure 5.3 In vitro cytotoxicity assays. Supernatants of the C. difficile 6 3 0 0 e r m m
strains were used in cell culture assays to measure cytotoxicity. Vero cells (a) and 
HT29 cells (b) were cultured to a flat monolayer before adding C. difficile 
supernatants in a fourfold dilution series. After 24 hour incubation, toxin end point 
titres were determined. 
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5.2.2.1 Growth of C. difficile 630Aerm (pMTL84151::agr2) in BHIS 
medium 
To assess whether there are any growth differences between C. difficile 6308.erm 
(pMTL84151::agr 2), C. difficile 6308.erm and C. difficile R20291, the C. difficile 
strains were cultivated in BHIS broth for 24 h, and growth was monitored by 
measuring the change in OD600 (Figure 5.4). All strains showed highly similar 
growth characteristics, which allows for the exclusion of growth differences when 
interpreting the subsequent experiments in this chapter. 
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Figure 5.4 Growth of C. difficile 6308.erm strains in BHIS broth over five days. 
Strains were cultivated as described in Chapter Two, and the OD600 measured. The 
symbols represent the averages of three independent experiments, and the error bars 
represent standard errors of the means. 
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5.2.2.2 Sporulation in C. difficile 630Aerm carrying pMTL84151::agr2 
Sporulation assays were used to address whether presence of the agr2 locus changes 
the sporulation profile of C. difficile 630l1erm and its ability to form heat-resistant 
cfu on BHIS agar supplemented with taurocholate over a five day period (Figure 
5.6). C. difficile 630l1erm harbouring pMTL84151::agr2 appeared to have no effect 
on colony formation after heat treatment. Sporulation in all the strains was initiated 
at 24 hours. The level of heat resistant CFU formed by C. difficile carrying the empty 
plasmid was slightly lower than the C. difficile 63011erm. These results indicate that 
agr2 in C. difficile 630l1erm background does not alter the onset of sporulation in 
this strain. 
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Figure 5.5 Development of heat-resistant CFU of C. difficile 630l1erm harbouring 
pMTL84151::agr2 over 5 days on BHIS agar supplemented with 0.1% taurocholate. C. 
difficile strains were cultivated as described in Chapter Two. The symbols indicate the 
averages of three independent experiments, and the error bars indicate standard errors of the 
means. The detection limit for the assay was 50 CFU/ml. 
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5.3 Discussion 
The work described in Chapter 4 showed that the second agr2 locus may playa role 
in toxin A and toxin B production in C. difficile R20291. Therefore in light of these 
findings, the work described in this study set out to further characterise the agr 2 
locus by (i) investigating transcriptional linkage of the agr genes and (ii) 
investigating the effect on toxin A and toxin B production in the C. difficile 6 3 0 ~ e r m m
strain harbouring a plasmid containing the agr210cus. 
The RT-PCR results revealed that all the genes within agr region 1 and agr region 2 
are co-expressed. A positive RT -PCR result was obtained for all gene pairs tested 
with the exception of gene pairs pts! and CD2641. However, there was no 
amplification from the positive control in this reaction either. The primer pairs were 
tested prior to being used in the RT-PCR reactions. The primers that were designed 
to amplify ptsVCD2753 were tested on a genomic DNA template using a Phusion 
Taq polymerase to ensure the primers were annealing correctly and there was no 
non-specific amplification. The results of the test showed that the primers annealed 
and amplified as expected, data not shown. 
All gene pairs which are co-expressed show expression throughout early and late 
exponential growth and there is no obvious difference in the levels of expression at 
the two time points analysed. It should be noted that analysis of transcriptional 
linkage using RT-PCR is not necessarily a quantitative method and therefore, we 
were unable to predict the size of the mRNA transcript using these results. A 
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Northern blot is a more quantitative method which would enable us to determine the 
actual size of the mRNA transcript. 
The agr regions in other clostridia species, such as C. perfringens and C. botulinum, 
have been shown to form an operon and be transcribed from a single RNA transcript 
(Ohtani et al., 2009; Cooks ley et al., 2010). These findings are consistent with what 
has been shown in S. aureus and other gram positive bacteria that carrying an agr 
operon. However, this does not seem to be apparent for C. difficile strains 630 and 
R20291. Our data suggests that maybe the agr genes in C. difficile 630 and C. 
difficile R20291 are not transcribed as a single operon. 
We demonstrated that introduction of the agr2 locus into the C. difficile 6 3 0 ~ e r m m
strain on a plasmid, increases the cytotoxicity of this strain in vitro. Interestingly, the 
cytotoxicity levels of this recombinant strain mirrored the cytotoxicity shown by C. 
difficile R20291. These findings further support the work described in the previous 
chapter, and suggests that the second agr locus in C. difficile R20291 may be a 
contributing factor in increased toxin production phenotype that is observed in PCR 
ribotype 027 strains. It would be interesting to analyse the effect of adding culture 
supernatant taken from the C. difficile R20291 agr2 mutant strains to C. difficile 
6 3 0 ~ e r m m cells to see whether the increase in cytotoxicity occurs in the absence of 
AlP 1 and AIP2 peptides. Further work needs to be undertaken to fully elucidate the 
role of agr 2 in this strain. 
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Surprisingly, C. difficile 630!1erm harbouring pMTL84151::agr2 appeared to have 
no effect on colony formation after heat treatment. Sporulation in all the strains was 
initiated at 24 hours. The level of heat resistant CFU formed by C. difficile carrying 
the empty plasmid was slightly lower than the C. difficile 630!1erm. These results 
indicate that agr2 in C. difficile 630!1erm background does not alter the onset of 
sporulation in this strain. We observed that sporulation in the C. difficile R20291 
occurs after 48 hours, whereas sporulation in C. difficile 630!1erm harbouring 
pMTL84151 : :agr 2 occurs after 24 hours consistent with its parental strain. Even 
though it is difficult to draw any definite conclusions from these observations, it is 
clear sporulation in C. difficile is regulated by many different factors and regulation 
by the agr locus may only be one part of this very complex process. 
Key outcomes: 
I. All the genes within the agr 1 region , from C. difficile 630 and C. difficile 
R2029 1 , and all the genes within agr region 2 of C. difficile R20291 are co-
expressed. It was not possible to determine whether the agr genes are 
transcribed on a single mRNA transcript using this method. 
2. Introducing the agr2 locus into a C. difficile 630!1erm background increases 
the cytotoxicity levels of this strain to a similar level of cytotoxicity that is 
displayed by C. difficile R20291. An increased cytotoxicity level means more 
toxin A and toxin B is being produced in this recombinant strain. 
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Chapter 6 
Analysis of a luxS-type signalling system in 
Clostridium difficile 
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6.1 Introduction 
luxS homologues can be found in a variety of Gram-positive and Gram-negative 
bacteria (Winzer et al., 2003). The quorum sensing molecule auto inducing-2 (AI-2) 
is synthesised by the luxS gene. LuxS is a metabolic side product produced during 
the activated methyl cycle (a recycling pathway involved in the metabolism of 
methionine) (Winzer et al., 2003). The AI-2 molecule is produced by many different 
Gram-negative and Gram-positive species (Bassler et al., 1997) and AI-2 signalling 
systems are involved in the regulation of virulence factors such as type II secretion in 
enterohaemorrhagic E. coli (Sperandio et al., 1999) and haemolysin and cysteine 
protease in Streptococcus pyogenes (Lyon et al., 2001). As luxS homologues have 
been found in many different bacteria, it has recently been proposed that AI-2 could 
serve as a 'universal signal' for interspecies cross-talk (Xavier & Bassler, 2003). 
However, this is yet to be proven in species other than Vibrio. 
6.1.2 The role of LuxS in clostridia 
Several clostridia, including C. difficile, have been found to possess LuxS 
homologues. In C. botulinum the luxS gene shows 50.3% sequence identity with that 
of V. harveyi, but limited literature is available on its mechanism of control of 
cellular functions. To date, there is only one documented report on the function of C. 
botulinum luxS (Zhao et al., 2006). This group demonstrated that AI-2 was present in 
C. botulinum culture supernatant and that this supernatant promoted the germination 
and outgrowth of spores. However, there is no evidence to suggest that this 
promotion was directly due to the effect of AI-2. 
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LuxS has also been investigated in other clostridial species and indeed, Ohtani et al. 
(2002) showed that the luxS gene is involved in the regulation of toxin production in 
C. perfringens via quorum sensing. This group also demonstrated that luxS mutants 
produced much less a, K and e toxins than the wild type, and that these mutants 
could be complemented with wild type culture supernatant to restore toxin 
production. 
6.1.3 Previous knowledge of LuxS in C. difJicile 
The study of quorum sensing in C. difjicile is also gathering momentum, due to the 
emerging incidence of C. difficile-associated disease (CDAD) in hospitals. However 
it can be fair to say that our previous knowledge about the role of luxS in C. difjicile 
remains limited. Carter et al. (2005) demonstrated that AI-2 is produced by this C. 
difjicile. In the region upstream of luxS, genes encoding a putative two component 
signal transduction system were identified, and the system was found to be involved 
in the regulation of AI-2 production. However, they suggested that AI-2 was not 
involved in the control of toxin production, as down-regulation of the luxS gene 
using antisense RNA did not cause a reduction in toxin production. 
In contrast to these findings Lee & Song (2005) also carried out a similar study into 
luxS and quorum sensing in C. difjicile. They demonstrated an up-regulation of toxin 
A mRNA production in response to exposure to AI-2-containing C. difjicile 
supernatant. However, they could not demonstrate a concomitant increase in the 
level of the toxin. Their data do suggest, however, that luxS plays some role in the 
regulation of toxin production in C. difjicile. 
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Homologues of luxS have been identified in the genome sequence of both C. difjicile 
630 and C. difficile BIINAPII027 strain, R20291. We reasoned that the AI-2/LuxS 
signalling system plays a role in the regulation of virulence factors in C. difjicile. 
Therefore it was decided to target luxS in both C. difficile 6 3 0 ~ e r m m and C. difjicile 
R2029 1. 
6.1.4 Aims of this study 
With a range of genetic tools now at our disposal, the way has been opened to 
understand more thoroughly the role of luxS in C. difjicile QS-mediated regulation of 
virulence factors. The study presented in this chapter, therefore, aimed to utilise the 
ClosTron system to inactivate luxS homologues in both C. difficile 6 3 0 ~ e r m m and 
R20291, and analyse the role played by these genes in the regulation of virulence 
factors, paying particular attention to sporulation and toxin production in the first 
instance. 
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6.2 Results 
6.2.1 Construction of mutant strains 
To investigate the role of luxS in C. difJicile, the ClosTron system (Heap et al., 2007; 
Heap et al., 2009; Heap et al., 2010) was used, to create independent insertional 
mutants of C. difJicile 630derm and C. difJicile R20291 in which the luxS gene was 
inactivated, yielding strains C. difJicile 630derm luxS: :CT ermB and C. difJicile 
R20291 luxS::CTermB, respectively. The group II intron from the ClosTron system 
was retargeted using a computer algorithm to insert into luxS in a sense orientation at 
position 48 bp, from the start of the ORF, and in an antisense orientation at position 
161 bp. 
As described in previous chapters, to confirm correct ClosTron insertion, putative 
mutant strains were analysed by PCR, and one erythromycin/lincomycin-resistant 
clone each of C. difJicile 630derm luxS: :CT ermB and C. difJicile R20291 
luxS::CTermB were picked for sequencing at the intron insertion site and the data 
confirmed the expected sequence (Table 6.1 shows intron insertion sites and the 
frequencies of the desired mutants obtained). 
Construction of a luxS insertional mutant was first attempted in C. difJicile 630derm 
using the 48s target site. However, it was not possible to isolate the desired mutant 
using this target site. Screening of a pool of genomic DNA from >50 erythromycin-
resistant clones indicated that no desired mutants were present. The intron or target 
site was therefore judged to be inefficient (as can occasionally occur when using 
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group II intron technology), so another target site (base 161 with the antisense 
orientation) was chosen for luxS. This target site was successful in targeting the 
intron and subsequently after PCR screening a luxS insertional mutant in both C. 
difficile strains was obtained. 
Strain and target site 
C. difficile 630derm luxS 48s 
C. difficile 630derm luxS 161 a 
C. difficile R20291 luxS 161 a 
Frequency of desired mutant among 
clones screened 
% No. positive/no. screened 
o 0/50+ 
100 5/5 
100 5/5 
Table 6.1. ClosTron insertion frequencies with erythromycin selection. Introns were 
inserted after the indicated number of bases from the start of the open reading frame 
in either the sense (s) or antisense (a) orientation. Erythromycin-resistant (630derm 
or R20291) clones were picked at random and screened by PCR to amplify the 
intron-exon junction. One clone of each desired mutant was selected, and the intron 
insertion site verified by sequencing. 
6.2.2 Phenotypic characterisation of the C. difficile luxS mutant strains 
C. difficile 630derm luxS::CTermB and C. difficile R20291 luxS::CTermB were 
phenotypically characterised. To ensure that any observed phenotypes of the C. 
difficile luxS mutants are not a result from growth deficiencies, the change in OD600 
was used to monitor growth over 24 hours in BHIS broth (Figure 6.1 and 6.2). The 
growth of the mutants in both C. difficile strains was found to be indistinguishable 
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from the growth of the parental strain, which suggests that there were no obvious 
growth defects following inactivation of luxS, in C. difficile 6 3 0 0 e r m m and R20291 . 
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Figure 6.1 The growth of C. difficile 6 3 0 0 e r m m luxS mutant strain in BHIS broth, as 
indicated by the change in OD600, during a 24 hour period. The symbols represent the 
averages of three independent experiments, and error bars indicate standard errors of 
the means. 
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Figure 6.2 The growth of C. difficile R20291 luxS mutant strain in BHIS broth, as 
indicated by the change in OD600, during a 24 hour period. The symbols represent the 
averages of three independent experiments, and error bars indicate standard errors of 
the means. 
6.2.2.1 Sporulation in the C. difficile luxS mutant strains 
Following inactivation of luxS in both C. difficile 6 3 0 ~ e r m m and R20291 , the luxS 
mutant strains were tested to determine their ability to form heat-resistant CFU over 
a 5-day period on BHIS agar supplemented with the bile salt taurocholate (Figure 6.3 
and 6.4). Heat-resistant cfu/ml (spores) were enumerated by serial dilution and 
plating onto BHIS agar supplemented with 0.1 % of the bile salt taurocholate after 
heat treatment for 30 mins at 60°C, respectively as described in Chapter 2. It appears 
that over 5 days there is no effect on sporulation in the C. difficile 6 3 0 0 e r m m luxS 
mutant strain. Inactivation of luxS had no effect on sporulation in C. difficile 
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R20291. The mutant strains were able to form heat-resistant CFU over the 5-day 
period at the same rate as the parental strain. This suggests that /uxS is not involved 
in sporulation and/or germination in C. difficile. 
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Figure 6.3 The development of heat-resistant CFU of C. difficile 6 3 0 ~ e r m m /uxS mutant 
strain over five days. The symbols represent the averages of three independent 
experiments, and error bars indicate standard errors of the means. The detection limit 
for colony counts was 50 CFU/ml. 
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Figure 6.4 The development of heat-resistant CFU of C. difficile R20291 luxS mutant 
strain over five days. The symbols represent the averages of three independent 
experiments, and error bars indicate standard errors of the means. The detection limit 
for colony counts was 50 CFU/ml. 
6.2.2.2 Toxin production in the C. difficile luxS mutant strains 
In order to understand if luxS is involved in the regulation of toxin A and B 
production in C. difficile, in vitro cell cytotoxicity assays were carried out. Cells 
were incubated for 24 hours with a fourfold dilution series of C. difficile culture 
supernatants. The C. difficile 6 3 0 0 e r m m luxS mutant showed a similar degree in 
toxicity towards both the vero cells and HT29 as the parental strain. Also there was 
no obvious difference in cytotoxicity between the C. difficile R20291 luxS mutant 
and the parental strain (Figure 6.5a, b). The cytotoxicity results indicate that the luxS 
is not involved in the regulation of toxin A and toxin B production in C. difficile 
R2029 1. 
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Figure 6.5 In vitro cytotoxicity assays. Supernatants of the parental strain and the 
two iuxS mutant strains were used in cell culture assays to measure cytotoxicity. 
Vero cells (a) and HT29 cells (b) were cultured to a flat monolayer before adding C. 
difficile supernatants in a fourfold dilution series. After a 24 hour incubation, toxin 
end point titres were determined. 
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6.3 Discussion 
Quorum sensing systems have been discovered in many bacterial species and have 
been shown to be a widespread mechanism of gene regulation in bacteria. Highly 
conserved luxS homologues have been identified in both Gram-positive and Gram-
negative bacteria (Xavier and Bassler, 2003). In pathogenic bacteria AI-2 signalling 
systems play an important role in the regulation of virulence factors i.e. toxin 
regulation in C. perfringens (Ohtani et ai, 2002). The synthesis of AI-2 depends on 
the enzyme LuxS. 
Homologues of luxS have been identified in the genome sequences of both C. 
difficile 630 and C. difJicile R20291. Upstream of the luxS gene there is a 
transcriptional regulator (CD3599) and a sensor kinase (CD3600), which have been 
showed to be transcriptional linked by Carter et al. (2005) suggesting that this two-
component system could be involved with mediating the AI-2 molecule synthesised 
by LuxS. It has also been discovered a AI-2 signalling peptide is produced by C. 
difficile (Carter et al., 2005). The work described in this chapter set out to investigate 
the role of luxS in C. difJicile 630 and C. difficile R20291 and whether the expression 
of virulence factors are under regulatory control by a luxS-type signalling system. 
Inactivation of luxS appeared to have no effect on sporulation in C. difficile R20291. 
The mutant strain was able to form heat-resistant CFU over a 5-day period at the 
same rate as the parental strain. The same result was seen with the C. difJicile 
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630derm luxS mutant. This suggests that luxS is not involved in sporulation and/or 
germination in C. difficile. 
Cytotoxicity assays performed with C. difficile luxS mutants showed a similar 
degree of cytotoxicity in vitro in comparison to their parental strains. The 
cytotoxicity results indicate that the iuxS is not involved in the regulation of toxin A 
and toxin B production in C. difficile. Despite toxin production in C. perfringens 
being regulated by a luxSIAI-2 signalling system, it appears that in C. difficile toxin 
production is not under regulatory control of such cell signalling system. 
Unfortunately the precise mechanism by which toxin production and sporulation are 
regulated in C. difficile still remains unclear. The work presented above suggests that 
the production of the toxins and sporulation is not under the regulatory control of a 
luxS-type signalling system in C. difficile. It appears that the regulation of virulence 
factors in C. difficile is a very unique and complicated process. It may be possible 
that they are not under the regulatory control of a simple quorum sensing system and 
many extracellular and intracellular factors are involved in the regulation of 
sporulation and toxin production. Despite this, it remains clear that a further 
comprehensive analysis of regulation is required, for example DNA microarrays, to 
fully understand how toxin production and sporulation are regulated in C. difficile. 
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Chapter Seven 
General Discussion 
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7.1 Key findings in this study 
7.1.1 agr in C. difficile 630 
The work presented in Chapter Three described the initial characterisation of an 
agrB homologue and a number of putative response regulators for their role in 
sporulation and toxin production in C. difficile 630. This study showed that agrB 
plays no obvious role in the regulation of virulence factors in C. difficile 630. The 
data obtained from the three orphan response regulators, identified from the 
BLASTP search, suggest that these response regulators may not be the response 
regulator of the agrBD locus in C. difficile 630. Our data indicates that sporulation 
and toxin production are not under the regulatory control of an agr-QS based system 
in C. difficile 630. 
As with C. perfringens and C. botulinum, C. difficile 630 only has agrBD 
homologues and no apparent agrCIA homologues located in close proximately to the 
agrBD locus. A role of agr has been established in both of these clostridial strains; in 
both strains agr regulates toxin production. The genomic context of the C. botulinum 
and C. perfringens agr regions are similar. This feature is not seen in C. difficile. 
Even though it is unknown whether agr mutants in C. perfringens are impaired in 
sporulation, agr mutants in C. botulinum are. This indicates that these two clostridial 
species are more similar in terms of agr control than C. difficile. 
It remains unclear what role the agr system has in C. difficile 630 or even if agr has 
a functional role in regulation of virulence in C. difficile 630. With no apparent two-
component system (to detect the auto inducing peptide and induce gene expression) 
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present within the vicinity of the agrBD locus in genome sequence of C. difficile 
630, it may be possible that agr does not have a functional role in regulation in C. 
difficile 630. This could be determined by investigating whether agrD produces an 
autoinducing peptide (AIP) by trying to isolate it from culture supernatant using 
mass spectrometry. Further characterisation of the C. difficile 630 agrBD locus is 
needed in order to understand whether it is involved in C. difficile pathogenesis. 
7.1.2 agr in C. difficile R20291 
The recent increase in the number CDAD cases has been attributed to the rapid 
emergence of C. difficile strains belonging to restriction endonuclease type BI, North 
American pulsed-field type 1 (NAPl) and PCR-ribotype 027 (BIINAPII027) (Pepin, 
et al., 2004; Kuijper, et al., 2007). Patients infected with the PCR-ribotype 027 
strains have more severe diarrhoea, a higher mortality rate and a higher level of 
reoccurrence (Loo et al., 2008; Goorhuis et al., 2007; Redelings et at., 2007; Pepin 
et at., 2004). 
Studies have shown that a number of BIINAPl/027 strains produce higher levels of 
toxin in the laboratory, although the mechanisms for this increased toxin production 
remain unclear (Wamy, et al., 2005). In addition, it has been suggested that strains 
of the BIINAPlI027 type are more prolific in terms of sporulation than non-outbreak 
strains (Wilcox and Fawley, 2000; Fawley, et aI., 2007; Akerlund, et aI., 2008). 
However, to-date it is still not clear exactly what causes the increased disease 
incidence and severity associated with BIINAPlI027 strains of C. difficile. There are 
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a number of genes specific to PCR-ribotype 027 strains, a large proportion of which 
comprise of regulatory genes. Interestingly PCR -ribotype 027 strains carry an 
additional copy of the complete agr locus which is not found in the C. difJicile 630 
genome. 
The study presented in Chapter Four set out to investigate the role of the second agr 
locus in regulation of virulence factors in C. difficile R20291. The C. difJicile 
R20291 agrBl mutant showed a similar degree in toxicity towards both the vero 
cells and HT29 cells as the parental strain. However, both agr2 mutants of C. 
difJicile R20291 displayed a reduction in cytotoxicity in vitro (Figure 4.4). In light of 
these findings, it can be concluded that the agr2 locus may playa secondary role in 
the regulation of toxin production in C. difJicile. The exact mechanisms of how this 
is elucidated remains unclear however it could be possible that the two additional 
AIP's produced in this strain act as a molecular switch and increase toxin production. 
We observed that there is some variation in the sporulation profiles of the C. difficile 
R20291 agr mutants. There are no obvious differences in the rate at which the heat-
resistant cfu are formed over 5 days in the C. difficile R20291 agrA mutant strain in 
comparison to the parental strain. In the C. difJicile R20291 agrB2 mutant 
sporulation is initiated after 24 hours, whereas the parental strain sporulates after 48 
hours. On the other hand, the onset of sporulation in the C. difJicile R20291 agrBl 
mutant is delayed, heat-resistant cfu are formed after 72 hours, in comparison to the 
parental strain. The delayed onset of sporulation was fully restored in C. difJicile 
R20291 agrBl mutant strains carrying pMTL84151::agrBDl and the complemented 
agrBl mutant behaved in a similar manner to the C. difJicile R20291 parental strain 
(Figure 4.5). 
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We observed differences in the sporulation profiles of the agrB and agrBl mutant 
strains of C. difJicile 6 3 0 ~ e r m m and C. difJicile R2029 I , respectively. Sporulation in 
the agrB mutant of C. difJicile 6 3 0 ~ e r m m occurs after 24 hours whereas in the C. 
difJicile R20291 agrBl mutant sporulation is initiated much later, after 72 hours. 
This suggests that the agrBD loci in the two C. difJicile strains may have different 
regulatory roles. It is not clear why it would be beneficial for C. difJicile R20291 to 
indirectly regulate the initiation of sporulation in this way, as the delay in the onset 
of sporulation is not seen in the C. difJicile 6 3 0 ~ e r m m agrB mutant. It could be that 
this is a phenomenon that only occurs in C. difJicile R20291. However, it would be 
interesting to determine whether this sporulation profile is a characteristic of all 
PCR-ribotype 027 strains, as well as other C. difJicile strains that carry the agr2 
locus. 
A comparative study of UK and European clinical isolates of PCR-ribotype 027 
strains revealed that the agr2 locus is present in genomes of 86% of the strains 
tested, two of which were non-toxigenic strains (Marsden et al., 2010). If the agr2 
locus is present in non-toxigenic strains it may be feasible that the increased 
virulence exhibited by the PCR-ribotype 027 strains is not a consequence of carrying 
the additional agr2 locus. On the other hand, it could also be said that the agr2 locus 
is not functional in the non-toxigenic C. difJicile strains. 
The characterisation of the agr2 locus described in Chapter Four and Chapter Five 
has suggested a possible role of the agr genes in sporulation and toxin production in 
C. difJicile, although it is obvious that the agr2 locus must be further analysed to 
determine the role that it may be playing in regulation of C. difficile virulence. In 
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particular, it is necessary to complement the defect in the initiation of sporulation 
and the reduction of toxin production that was observed in the agr mutants, in order 
to show that the observed phenotypes was a specific consequence of the inactivation 
of the agr2 genes. However, initial attempts to complement the sporulation defect in 
the agrB2 mutant were not successful. As described in Chapter Two, plasmid 
pMTL84151::agr2 was constructed, carrying the parental agr2 locus coding region, 
the 400 bp region immediately upstream of the open reading frame presumed to 
contain its promoter and 269 bp region immediately downstream of the agr2 locus. 
This plasmid was introduced into the agrB2 mutant strain of C. difficile R2029 I , but 
the initiation of sporulation in this 'complemented' mutant strain occurred after 24 
hours, the same as the agrB2 mutant strain. This suggests that pMTL84151: :agr 2 
was not suitable for complementing the sporulation defect observed in the agrB2 
mutant strain. There are a number of reasons why this sporulation defect was not 
restored following expression of pMTL84151::agr2. Identification of a putative 
agr2 promoter region was based on speculation that the promoter would be located 
immediately upstream of agr2 locus. However, it appears that the 400 bp region 
immediately upstream of the open reading frame may not contain its promoter and it 
is therefore possible that a suitable promoter lies further upstream of the agr2 locus. 
Identification of this promoter could be achieved using techniques such as primer 
extension but, alternatively, use of a known strong promoter may allow for efficient 
expression of agr2 locus when attempting complementation studies in the agr2 
mutant strains. 
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Other explanations for the failure of pMTL84151::agr2 expreSSIOn In the 
complementation studies of the C. difficile R20291 agr mutants include the loss of 
pMTL84151 : :agr 2 during cultivation in the sporulation medium, altered sporulation 
frequency of mutant strains carrying pMTL84151::agr2 (this effect could be 
analysed by observing spores under phase-contrast microscopy), or indeed the 
possibility that the observed mutant phenotype is not a consequence of inactivation 
of agr2, instead a result of a potential second ClosTron insertion. This could be 
clarified by using Southern Blot analysis to identify intron insertions in the agr2 
mutant strain. The observed mutant phenotypes could also be the result of a 
spontaneous mutation, which cannot be confirmed by any method. In such case, the 
obvious approach would be to create further identical mutants and then attempt to 
complement their respective mutant phenotypes. 
7.1.3 Transcriptional analysis of the agr operon 
Transcriptional linkage of the agr genes was investigated using the RT-PCR. Our 
results revealed that all the genes within agr region 1 and agr region 2 are co-
expressed and show expression throughout early and late exponential growth; there 
is no obvious difference in the levels of expression at the two time points analysed. 
A positive RT-PCR result was obtained for all gene pairs tested with the exception 
of gene pairs pIs! and CD2641. However, there was no amplification from the 
positive control in this reaction either. The primer pairs were tested prior to being 
used in the RT-PCR reactions. The primers that were designed to amplify 
ptsIlCD2753 were tested on a genomic DNA template using a Phusion Taq 
polymerase to ensure the primers were annealing correctly and there was no non-
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specific amplification. The results of the test showed that the primers annealed and 
amplified as expected, data not shown. 
The agr regions in other clostridia species, such as C. perfringens and C. botulinum, 
have been shown to form an operon and be transcribed from a single RNA transcript 
(Ohtani et al., 2009; Cooksley et al., 2010). These findings are consistent with what 
has been shown in S. aureus and other gram positive bacteria that carrying an agr 
operon. However, this does not seem to be apparent for C. difficile strains 630 and 
R20291. Our data suggests that maybe the agr genes in C. difficile 630 and C. 
difficile R20291 are transcribed on a polycistronic mRNA and not as a single operon. 
Further studies need to be undertaken to determine this. Analysis of transcriptional 
linkage using RT-PCR is not necessarily a quantitative method and therefore, we 
were unable to predict the size of the mRNA transcript using these results. A 
Northern blot is a more quantitative method which would enable us to determine the 
actual size of the mRNA transcript. 
7.1.4 agr2 and C. difficile 630Aerm 
We demonstrated that introduction of the agr2 locus into the C. difficile 630derm 
strain on a plasmid, increases the cytotoxicity of this strain in vitro. Interestingly, the 
cytotoxicity levels of this recombinant strain mirrored the cytotoxicity shown by C. 
difficile R20291. These findings further support the work described in the previous 
chapter, and suggests that the second agr locus in C. difficile R20291 may be a 
contributing factor in increased toxin production phenotype that is observed in PCR 
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ribotype 027 strains. It would be interesting to analyse the effect of adding culture 
supernatant taken from the C. difficile R20291 agr2 mutant strains to C. difficile 
630derm cells to see whether the increase in cytotoxicity occurs in the absence of 
AIPI and AIP2 peptides (assumed to be processed by AgrBl and AgrB2, 
respectively). Further work needs to be undertaken to fully elucidate the role of agr2 
in this strain. 
Surprisingly, C. difficile 630derm harbouring pMTL84151::agr2 appeared to have 
no effect on heat resistant colony formation after heat treatment. Sporulation in all 
the strains was initiated at 24 hours. The level of heat resistant cfu formed by C. 
difficile carrying the empty plasmid was slightly lower than the C. difficile 630derm. 
These results indicate that agr2 in C. difficile 630derm background does not alter the 
onset of sporulation in this strain. We observed that sporulation in the C. difficile 
R20291 occurs after 48 hours, whereas sporulation in C. difficile 630derm 
harbouring pMTL84151: :agr2 occurs after 24 hours consistent with its parental 
strain. 
Sporulation in organisms such as B. subtilis has been extensively studied 
(Sonenshein, 2000). On the other hand, the conditions which lead to sporulation 
initiation in C. difficile are not clear and our understanding of this complex process 
in C. difficile remains poor. Even though it is difficult to draw any definite 
conclusions from our observations, it is clear sporulation in C. difficile is regulated 
by many different factors and regulation by the agr locus may only be one factor of 
this very complex process. 
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7.1.5 LuxS/AI-2 signalling in C. difficile 
Inactivation of luxS homologues in C. difficile 6 3 0 ~ e r m m and C. difficile R20291 had 
no obvious effect on sporulation and toxin production, suggesting that C. difficile 
does not use the AI-2 autoinducer to regulate these processes. It has been reported 
that luxS is transcribed at higher levels during late exponential growth when AI-l 
production is maximal (Carter et al., 2005). Toxin production in C. difficile is 
maximal during stationary growth phase. Thus is not obvious how a LuxSI AI -2 QS 
signalling system could regulate the production of toxins in C. dtfficile, as the toxins 
are maximally produced after the AI-2 signal molecule is depleted. Although LuxS is 
involved in toxin production in C. perjringens, inactivation of luxS in C. difJicile 
does not have an effect on virulence. The data presented in this study further 
supports the theory that LuxS is a metabolic side product produced during the 
activated methyl cycle and does not have a role in quorum sensing (Winzer et al., 
2003). The findings of Doherty et al. (2006) demonstrated that the inactivation of 
luxS in Staphylococcus aureus had no effect on virulence-associated traits. It is 
possible that the phenotypic changes observed in some bacteria following 
inactivation of luxS, may be due to the absence of the AI-2 signal molecule, but they 
could also be attributed to the disruption of the activated methyl cycle (Winzer et al. , 
2003). 
7.2 Future research 
7.2.1 Furthering our understanding of agr in C. difficile 
To date it is still not clear what role agr plays in the regulation of virulence in C. 
difficile. Our investigation into agr regulation of virulence factors has only scratched 
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the surface. This work presented in this thesis mainly focussed on screening agr 
mutants with two phenotypes, toxin production and sporulation. The main reason for 
this was that at the time this study began these two assays were developed in our 
laboratory. Unlike C. perfringens and C. botulinum in which agr system regulates 
toxin production (and sporulation in C. botulinum), agr in C. difficile may be 
involved in the regulation of other virulence factors or metabolic pathways. Analysis 
of the transcriptional profiles of the agr mutants will be useful to identify what other 
virulence factors or metabolic pathways are regulated by the agr system in C. 
difficile. Once it has been revealed what processes or pathways are regulated by agr, 
it will be easier to characterise mutants by assaying a phenotype known to be 
regulated by the agr locus. 
Preliminary microarray studies with the C. difficile R20291 agrA mutant were 
commenced as part of this study however due to time constraints we were unable to 
present the data in this thesis as the data analysis has not been completed. RNA was 
extracted from the wildtype and mutant strains during early and late 
exponential/stationary growth, when OD600 readings were 0.4 and 1.2. Preliminary 
analysis of the microarray data revealed that in the agrA mutant strain, expression of 
the PaLoc (pathogenecity locus which encodes the toxin A and B genes) is 
upregulated during late exponential/stationary growth (R. Stabler, personal 
communication). This contradicts our observation that there is a decrease in 
cytotoxicity in the agrA mutant towards the vero and HT29 cells. One way to 
confirm our observation that there is a reduction in toxin production in the agrA 
mutant would be to perform quantitative PCR with reverse transcription (qRT-PCR) 
analysis. 
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A follow-up to this study would be a comprehensive analysis into the regulation of 
virulence factors in a wider range of C. difJicile strains, incorporating many more 
isolates from many more types of C. difJicile. Only with such a study will it be 
possible to make a more definitive statement about how sporulation and toxin 
production is regulated in different C. difJicile strains and types, and its subsequent 
role in disease incidence and severity. 
7.3 Concluding Remarks 
Our knowledge of how C. difJicile regulates the production of virulence and whether 
quorum sensing is involved in these processes remains limited. However, the work 
presented in this study has shown that the agr system may be involved in toxin 
production and sporulation. agr mutant strains exhibited a substantial reduction in 
the production of toxins and the sporulation profiles of these mutant strains vary 
greatly in comparison to the parental strains. Reports to-date have only scratched the 
surface in furthering our understanding of the regulation of virulence in C. difJicile, 
but with a range of genetic tools now at our disposal (Heap, et al., 2007; Heap, et al., 
2009; Heap, et at., 2010), the way is open to understand more thoroughly this 
important aspect of CDAD and thereby develop effective intervention strategies. 
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